vancomycin has been researched along with ciprofloxacin in 484 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 32 (6.61) | 18.7374 |
| 1990's | 94 (19.42) | 18.2507 |
| 2000's | 126 (26.03) | 29.6817 |
| 2010's | 167 (34.50) | 24.3611 |
| 2020's | 65 (13.43) | 2.80 |
| Authors | Studies |
|---|---|
| Maiese, WM; Singh, MP; Timmermann, BN; Wächter, G; Woldemichael, GM | 1 |
| Inagaki, H; Kawakami, K; Kawato, HC; Matsuhashi, N; Miyauchi, RN; Miyauchi, S; Ohki, H; Takahashi, H; Takemura, M | 1 |
| Barnes, M; Brown, NC; Butler, M; Gambino, J; LaMarr, W; Long, ZY; Wright, GE; Xu, WC; Zhi, C | 1 |
| Angehrn, P; Buchmann, S; Funk, C; Gmuender, H; Goetschi, E; Hebeisen, P; Kostrewa, D; Link, H; Luebbers, T; Masciadri, R; Nielsen, J; Reindl, P; Ricklin, F; Schmitt-Hoffmann, A; Theil, FP | 1 |
| Appelbaum, PC; Bhawsar, SB; Bozdogan, B; de Souza, NJ; Desai, VN; Deshpande, PK; Gupte, SV; Hooper, DC; Jacobs, MR; Jha, R; Khorakiwala, HF; Patel, MV; Shetty, N; Shukla, MC; Strahilevitz, J; Yeole, RD | 1 |
| Brown, NC; Butler, MM; Dix, EJ; Foster, KA; Holm, K; LaMarr, WA; Lamothe, S; Long, ZY; Manikowski, A; Motorina, I; Skow, DJ; Storer, R; Tarantino, PM; Wright, GE; Zhi, C | 1 |
| Eldridge, GR; Garo, E; Goering, MG; Hough, GW; Hu, JF; O'Neil-Johnson, M | 1 |
| Bae, T; Chen, PR; Duguid, EM; He, C; Rice, PA; Schneewind, O; Williams, WA | 1 |
| Duewelhenke, N; Eysel, P; Krut, O | 1 |
| Cohen, DE; Kanaya, F; Mayer, KH; Szumowski, JD | 1 |
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Hashimoto, A; Lucien, E; Marlor, CW; Nelson, DM; Ou, Y; Pais, GC; Podos, SD; Pucci, MJ; Song, Y; Thanassi, JA; Thoma, CL; Wang, Q; Wiles, JA | 1 |
| Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA | 1 |
| Cohen, MA; Ellsworth, E; Gage, JW; Gibson, GW; Gracheck, SJ; Hanna, DL; Huband, MD; Skerlos, LA; Stier, MA; Sulavik, MC; Zurack, M | 1 |
| Kwon, DH; Lu, CD | 1 |
| Cheung, A; Götz, F; Herbert, S; Meehl, M | 1 |
| Jansen, WT; Milatovic, D; Verel, A; Verhoef, J | 1 |
| Chu, D; Heine, H; Ip, E; Lovchik, J; Lyons, CR; Maples, KR; Olsufyeva, EN; Plattner, JJ; Preobrazhenskaya, MN; Printsevskaya, SS; Solovieva, SE; Wheeler, C; Zhang, YK | 1 |
| Bryce, E; Gravel, D; Loeb, M; Louie, L; Matlow, A; McGeer, A; Mulvey, M; Ofner-Agostini, M; Simor, AE; Stuart, TL; Watt, C | 1 |
| Alder, JD; Mascio, CT; Silverman, JA | 1 |
| Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
| Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
| Arhin, FF; Belley, A; Draghi, DC; Grover, P; McKay, GA; Moeck, G; Parr, TR; Sahm, DF; Sarmiento, I | 1 |
| Castanheira, M; Deshpande, LM; DiPersio, J; Jones, RN; Mendes, RE; Saubolle, MA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Benton, BM; Debabov, DV; Difuntorum, S; Krause, KM; Renelli, M; Wu, TX | 1 |
| Béliveau, C; Labbé, AC; Laverdière, M; Louie, T; Maccannell, D; Pépin, J; Poirier, L; Savoie, M | 1 |
| Long, F; Rouquette-Loughlin, C; Shafer, WM; Yu, EW | 1 |
| Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
| Abreu, PA; Afonso, IF; Azevedo, AR; Bernardino, AM; Borges, JC; Cabral, LM; Castro, HC; da Silveira, FC; Frugulhetti, IC; Garrett, R; Leal, B; Pinheiro, LC; Rodrigues, CR; Santos, CC; Santos, DO; Vegi, PF | 1 |
| del Pozo, JL; Mandrekar, JN; Patel, R; Rouse, MS; Sampedro, MF; Steckelberg, JM | 1 |
| Ike, Y; Inoue, T; Tomita, H; Zheng, B | 1 |
| Chen, H; Chen, M; Du, N; Liu, Y; Niu, J; Shen, E; Wang, H; Ye, H | 1 |
| Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
| Bell, JM; Biedenbach, DJ; Jones, RN; Sader, HS; Turnidge, JD | 1 |
| Carr, GJ; Clarke, M; Francis, L; Hopp, DC; Irigoyen, M; Jacobsen, D; Luche, M; Mocek, U; Rabenstein, J; Rhea, J; Romari, K; Smith, C | 1 |
| Abood, N; Boykin, DW; Hu, L; Kully, ML | 3 |
| Fritsche, TR; Jones, RN; Sader, HS | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Hafkin, B; Hoban, DJ; Kaplan, N; Karlowsky, JA; Zhanel, GG | 1 |
| Brunner, LS; Haas, W; Lee, JC; Morris, TW; Pillar, CM; Zurenko, GE | 1 |
| Chen, D; Huang, X; Jia, Z; Li, X; Wu, N; Zhang, A | 1 |
| Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
| Bavari, S; Bowlin, T; Butler, MM; Gussio, R; Houseweart, C; Lane, D; Moir, DT; Nguyen, T; Opperman, T; Panchal, RG; Peet, NP; Ulrich, RL; Williams, JD | 1 |
| Cheung, CM; Firestine, SM; Rybak, MJ; Vooturi, SK | 1 |
| Jain, R; Reddy, RP; Sharma, RK; Tegge, W | 1 |
| Inagaki, H; Ito, M; Kawakami, K; Matsuhashi, N; Miyauchi, R; Ohki, H; Takahashi, H; Takemura, M | 1 |
| Arhin, FF; Draghi, DC; Moeck, G; Parr, TR; Pillar, CM; Sahm, DF | 1 |
| Dempsey, S; Jack, C; Miller, CH; Nisa, S; O'Toole, R | 1 |
| Adibpour, N; Khalaj, A; Rajabalian, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bunders, C; Huigens, RW; Melander, C; Reed, CS; Reyes, S; Rogers, SA; Steinhauer, AT | 1 |
| Chen, HC; King, CH; Lai, JF; Lauderdale, TL; Shiau, YR | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Amsler, KM; Bush, K; Foleno, BD; He, W; Lynch, AS; Macielag, MJ; Morrow, BJ | 1 |
| Bavari, S; Bowlin, TL; Houseweart, C; Moir, DT; Opperman, TJ; Panchal, RG; Peet, NP; Williams, JD | 1 |
| Chen, D; Huang, X; Jia, Z; Li, X; Zhang, A | 1 |
| Ardanuy, C; Brito-Avô, A; Gonçalo-Marques, J; Liñares, J; Morais, A; Pires, R; Rolo, D; Santos-Sanches, I | 1 |
| Duan, Y; Hu, W; Li, M; Qian, Y; Shi, W; Yang, L | 1 |
| Dai, L; Huang, SY; Li, BB; Shen, JZ; Wang, MG; Wang, Y; Wu, CM; Xia, LN | 1 |
| Barrow, EW; Barrow, WW; Berlin, KD; Bourne, CR; Bourne, PC; Bunce, RA | 1 |
| Bavari, S; Bowlin, TL; Butler, MM; Moir, DT; Panchal, RG; Peet, NP; Shinabarger, DL; Williams, JD | 1 |
| Chan, JL; Cheung, GY; Joo, HS; Otto, M | 1 |
| Crandon, JL; Kuti, JL; Nicolau, DP | 1 |
| Baek, SY; Chae, SE; Cho, YL; Jeong, JW; Jung, SJ; Kim, YZ; Kwak, JH; Lee, HH; Lee, HS; Park, TK; Woo, SH | 1 |
| Ashby, CR; Hardej, D; Khadtare, NS; Kulkarni, SS; Singh, S; Talele, TT | 1 |
| Aubart, K; Duan, Y; Fang, Y; Hu, W; Ma, H; Shi, W; Yang, L; Zonis, R | 1 |
| Bradbury, BJ; Deshpande, M; Hashimoto, A; Kim, HY; Lucien, E; Nelson, DM; Pais, GC; Podos, SD; Pucci, MJ; Thanassi, JA; Wang, Q; Wiles, JA | 1 |
| Bradbury, BJ; Deshpande, M; Phadke, AS; Pucci, MJ; Thanassi, JA; Wiles, JA | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Barnes, MH; Brown, NC; Butler, MM; Dvoskin, S; Gambino, JJ; Long, ZY; Wright, GE; Xu, WC; Zhi, CX | 1 |
| An, LK; Chen, JW; Gu, LQ; Huang, ZS; Wang, LX; Wu, XW; Wu, ZP; Zhang, HB; Zhang, W | 1 |
| Do, TH; Huynh, TN; Ngo, TD; Thai, KM; Tran, CD; Tran, NC; Tran, TD | 1 |
| Koyama, N; Takahashi, Y; Tokura, Y; Tomoda, H | 1 |
| Kosikowska, U; Malm, A; Plech, T; Polz-Dacewicz, M; Rajtar, B; Wujec, M | 1 |
| Castro, HC; dos Santos, HM; Escobar, AC; Ferreira, VF; Jordão, AK; Leal, B; Novais, J | 1 |
| Bao, L; Cai, L; Chen, JL; Huang, P; Liu, HW; Liu, MM; Qi, QY; Wang, QX; Yang, JL; Yang, XL; Zhang, LX | 1 |
| Ashby, CR; Hardej, D; Patel, BA; Talele, TT | 1 |
| Brötz-Oesterhelt, H; Lai, D; Ola, AR; Proksch, P; Thomy, D | 1 |
| Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Franzyk, H; Frimodt-Møller, N; Jahnsen, RD; Nielsen, HM; Sandberg-Schaal, A; Vissing, KJ | 1 |
| Bisht, GS; Cameotra, SS; Lohan, S | 1 |
| Mishra, NN; Prabhakar, YS; Saquib, M; Sharma, S; Shaw, AK; Shukla, PK; Srivastava, R; Verma, S | 1 |
| Hu, W; Lv, F; Shi, W; Xing, D; Yang, L; Yang, S; Yang, Y; Zhao, Z | 1 |
| Alam, MZ; Bruhn, DF; Feng, L; Hurdle, JG; Lee, RB; Lee, RE; Maddox, MM; Narula, G; Sandhaus, S; Simmons, CJ; Sun, D; Tse-Dinh, YC; Tsutsumi, LS; Wu, X | 1 |
| Chen, X; Jacob, MR; Khan, IA; Kloepper, JW; Li, XC; Liles, MR; Mead, DA; Nasrin, S; Ravu, RR; Wang, M | 1 |
| Kaproń, B; Kosikowska, U; Malm, A; Paneth, A; Plech, T; Polz-Dacewicz, M; Rajtar, B; Stączek, P; Strzelczyk, A; Świątek, Ł | 1 |
| Banerjee, A; Chakrapani, H; Lahiri, S; Malwal, SR; Pardeshi, KA; Rangarajan, R | 1 |
| Al-Balas, Q; Al-Gharaibeh, M; Alali, F; Albataineh, H; Chen, WL; El-Elimat, T; Falkinham, JO; Oberlies, NH; Swanson, SM | 1 |
| Dai, HQ; Guo, H; Li, ZS; Song, FH; Wang, JG; Wang, WM; Zhang, LX; Zhang, XM | 1 |
| Bao, Y; Huang, X; Lan, S; Wang, T; Zhang, X; Zhu, S | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Blair, PM; Mitchell, DA; Molloy, EM; Tietz, JI | 1 |
| Lynch, AS; Ma, Z | 1 |
| Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
| Steenbergen, J; Tanaka, SK; Villano, S | 1 |
| Giang, NTK; Huong, DT; Quyen, TH; Thanh, ND; Toan, VN | 1 |
| Benfodda, Z; Bénimèlis, D; Boibessot, T; Dunyach-Rémy, C; Lavigne, JP; Lebeau, A; Meffre, P; Szurmant, H; Zschiedrich, CP | 1 |
| Long, TE; Sheppard, JG | 1 |
| Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Domalaon, R; Gorityala, BK; Goswami, S; Idowu, T; Lyu, Y; Schweizer, F; Shan, A; Yang, X; Zhanel, GG | 1 |
| Auer, JL; Cascio, F; Chowdhury, M; Hind, C; Picconi, P; Prabaharan, P; Rahman, KM; Sandiford, S; Sutton, JM; Wand, ME | 1 |
| Berscheid, A; Brötz-Oesterhelt, H; Chaidir, C; Daletos, G; Hartmann, R; Kalscheuer, R; Kassack, MU; Mokhlesi, A; Proksch, P; Rehberg, N; Stork, B; Stuhldreier, F; Sureechatchaiyan, P; Wesselborg, S; Wex, KW | 1 |
| Castro, HC; Costa, DCS; da Silva, FC; Ferreira, VF; Figueiredo, AMS; Lopes, SMM; Novais, JS; Pinho E Melo, TMVD | 1 |
| Frazier, KR; Geldenhuys, WJ; Hossain, MF; Long, TE; Saralkar, P; Sheppard, JG | 1 |
| Cizek, A; Imramovsky, A; Jampilek, J; Kauerova, T; Kollar, P; Michnova, H; Pauk, K; Pospisilova, S; Vinsova, J | 1 |
| Dellos-Nolan, S; English, A; Karmahapatra, S; Li, L; Li, Z; Mitton-Fry, MJ; Okumu, A; Wozniak, DJ; Yalowich, JC | 1 |
| Abutaleb, NS; Dayal, N; Mohammad, H; Naclerio, GA; Opoku-Temeng, C; Seleem, MN; Sintim, HO | 1 |
| Campos, VR; Castro, HC; Cunha, AC; da Silva, WA; de Souza, MCBV; Devillart, TADNS; Dias, FRF; Ferreira, MO; Ferreira, VF; Loureiro, RS; Novais, JS | 1 |
| Alam, MA; Duke, C; Gilmore, DF; Meeker, DG; Smeltzer, MS; Whitt, J; Zakeyah, AA | 1 |
| Ameryckx, A; Frédérick, R; Joris, B; Leimanis, S; Pochet, L; Poupaert, JH; Thabault, L; Van Bambeke, F; Wouters, J | 1 |
| Abdel Gawad, NM; Abdel-Aziz, MM; Abo-Ashour, MF; Abou-Seri, SM; Bhakta, S; Elaasser, MM; Eldehna, WM; George, RF; Gupta, A | 1 |
| Arya, G; Dalal, P; Kaur, M; Nimesh, S; Salunke, DB; Singh, R; Singla, P | 1 |
| Eswaran, S; Narayanan, S; Shivarudraiah, P; Shruthi, TG; Subramanian, S | 1 |
| Dang, LH; Dung, TT; Hai, DS; Kim Van, HT; Ky Duyen, NT; Mai, NT; Ngoc Bich, VT; Thanh Van, TT; Thanh, ND; Thu Hien, PT; Toan, DN; Toan, VN | 1 |
| Cai, S; Fang, Z; Guo, Q; Huang, X; Li, Y; Lin, H; Lu, YJ; Sun, N; Tang, Z; Wong, KY; Wong, WL; Yuan, W | 1 |
| Gao, F; Huang, G; Wang, T; Xiao, J | 1 |
| Barua, N; Blanchard, N; Chan, PK; Chan, ST; Hanquet, G; Ip, M; Lin, L; Ma, C; Qiu, Y; Shek, TL; Tsang, TF; Yang, X; Zhang, Y; Zuo, Z | 1 |
| Bi, F; Liu, X; Ma, S; Qin, Y; Song, D; Teng, Y; Zhang, N; Zhang, P | 1 |
| Beniwal, G; Chakrapani, H; Chopra, S; Dharmaraja, AT; Kamat, SS; Kelkar, DS; Kulkarni, A; Rajendran, A; Sankar, RK; Soni, I; Tamhankar, S | 1 |
| Apicella, C; Corso, G; D'Atanasio, N; Di Giorgio, FP; Furlotti, G; Garofalo, B; Magarò, G; Mangano, G; Ombrato, R; Prati, F; Robinson, D | 1 |
| Chen, T; Li, Z; Lyu, Y; Shan, A; Shang, L; Yang, Y; Zhu, J | 1 |
| Ali, Z; Bae, JY; Chittiboyina, AG; Khan, IA; Viljoen, AM; Wang, YH; Zaki, AA | 1 |
| Caljon, G; Cappoen, D; Claes, P; Cools, F; Cos, P; De Kimpe, N; de Macedo, MB; Delputte, P; Holvoet, F; Maes, L; Mangelinckx, S; Matheeussen, A; Meiresonne, T; Neyrolles, O; Piller, T; Semina, E; Torfs, E; Van Calster, K | 1 |
| Cheng, W; Kong, H; Wei, H; Yang, Z; Yuan, Y; Zhang, X | 1 |
| Augustynowicz-Kopeć, E; Bojanowski, K; Foks, H; Gobis, K; Głogowska, A; Korona-Głowniak, I; Krause, M; Siluk, D; Ziembicka, D | 1 |
| Klein, CD; van Oosten, LN | 1 |
| Duan, X; Huang, M; Kong, B; Nian, S; Peng, Y; Qin, J; Tan, X | 1 |
| Cockroft, NT; Dellos-Nolan, S; Gallucci, J; Koci, B; Lu, Y; Mitton-Fry, MJ; Okumu, A; Papa, JL; Wozniak, DJ; Yalowich, JC | 1 |
| Ameryckx, A; Frédérick, R; Pochet, L; Saadi, BE; Van Bambeke, F; Wang, G; Wouters, J; Yildiz, E | 1 |
| Abutaleb, NS; Alhashimi, M; Kassab, AE; Mayhoub, AS; Mohamed, KO; Seleem, MN; Shahin, IG; Taher, AT | 1 |
| Amada, H; Endo, M; Hitaka, K; Kamitani, M; Masuko, A; Mihara, Y; Mima, M; Ohtake, N; Sugiyama, H; Takata, I; Takeuchi, T; Tamura, Y; Tanaka-Yamamoto, N; Ushiyama, F; Wada, R | 1 |
| Clark, BR; Li, J | 1 |
| Dinh Thanh, N; Minh Tri, N; Ngoc Toan, V; Thi Thu Huong, N | 1 |
| Gou, S; Ni, J; Xie, J; Yao, J; Zhang, F; Zhong, C; Zhu, N; Zhu, Y | 1 |
| Alexandrova, LA; Avdanina, DA; Boykova, YV; Efimenko, TA; Efremenkova, OV; Glukhova, AA; Jasko, MV; Karpenko, IL; Kochetkov, SN; Kolonitskaya, DP; Kost, NV; Negrya, SD; Nuraeva, GK; Shevchenko, OV; Solodinin, AP; Solyev, PN; Volkov, IA; Zhgun, AA | 1 |
| Alam, MA; Basnakian, AG; Frangie, MM; Gilmore, DF; Hansa, RK; Khan, MMK; Savenka, AV; Shelton, RS; Shuttleworth, SL; Smeltzer, MS | 1 |
| Abouelhassan, Y; Chojnacki, M; Ding, Y; Dunman, PM; Fuse, MA; Huang, G; Huigens, RW; Jin, S; Kallifidas, D; Kundra, S; Lemos, JA; Liu, K; Luesch, H; Rohde, KH; Yang, H; Zhang, P | 1 |
| Chen, W; Gu, X; Guo, T; Ma, S; Song, D; Zhang, L; Zhang, N; Zhang, P | 1 |
| Agostinho, ÍRC; Araújo, AR; Campos, MAS; de Alcântara Oliveira, FA; de Carvalho Sousa, B; de Oliveira Castelo Branco, RR; Dos Santos Soares, MJ; Gonzalez, AGM; Lopes, AP; Pinheiro, REE; Rocha, JA | 1 |
| Ba, Z; Chang, L; Gou, S; Li, B; Liu, H; Ni, J; Ouyang, X; Zhang, J; Zhang, T; Zhang, Y; Zhong, C; Zhu, N; Zhu, Y | 1 |
| Chen, WM; Hou, W; Huang, MY; Lin, J; Meng, Y; Xu, XF; Yu, JH | 1 |
| Chen, W; Ma, S; Song, D; Zhang, N; Zhang, P; Zhang, S | 1 |
| Chen, A; Cummings, JE; Duncan, LR; English, A; Koci, B; Li, L; Lindert, S; Lu, Y; Mann, CA; McElroy, CA; Mitton-Fry, MJ; Nolan, S; Okumu, A; Papa, JL; Ratigan, SC; Roth, B; Seffernick, JT; Slayden, RA; Vibhute, S; Wozniak, DJ; Yalowich, J | 1 |
| Abugazleh, MK; Alam, MA; Ali, H; Gilmore, D; Raj Kc, H; Roy, S; Saleh, I | 1 |
| Akhoundsadegh, N; Alford, M; Drayton, M; Etayash, H; Hancock, REW; Straus, SK | 1 |
| Dayal, N; Onyedibe, KI; Sintim, HO | 1 |
| Cai, GX; Gopala, L; Zhang, PL; Zhang, SL; Zhou, CH | 1 |
| Bora, A; Deka, B; Devi, MV; Dihingia, A; Pahari, P; Sarma, S; Sen, T; Singh, AK; Suri, M | 1 |
| Choi, W; Efremov, RG; Konshina, AG; Lohan, S; Mandal, D; Maslennikov, I; Parang, K; Tiwari, RK | 1 |
| Guo, Y; Jia, G; Li, L; Wang, J; Wei, L; Xu, X; Yang, Y; Yu, Q; Zhou, Y | 1 |
| Lohan, S; Mohammed, EHM; Parang, K; Tiwari, RK | 1 |
| He, Q; Huan, X; Lan, L; Peng, X; Wang, Y; Xie, S; Yang, C; Zhang, X | 1 |
| Guo, XC; Huang, XH; Lu, YJ; Ser, HL; She, MT; Sun, N; Wong, WL; Zhang, YH; Zheng, BX; Zhong, DX | 1 |
| Andrés-Bilbao, M; Belmonte-Reche, E; Cebrián, R; de Paz, MV; Kuipers, OP; Li, Q; Lucas, R; Morales, JC; Peñalver, P | 1 |
| Collins, JA; Hazbón, MH; Hufnagel, D; Jahanbakhsh, S; Lu, Y; Mann, CA; Mitton-Fry, MJ; Moreno, J; Nolan, S; Osheroff, N; Papa, J; Parker, E; Stedman, TT; Thwaites, M; Vibhute, S; Wittum, T; Wozniak, DJ; Yalowich, JC | 1 |
| Chen, F; Chen, J; Ji, L; Liu, F; Qin, Y; Wang, S; Wang, Y; Wu, P; Xue, J | 1 |
| Gao, WW; Laiche, MH; Li, YL; Lin, JM; Zhang, PL; Zhou, CH | 1 |
| Aggarwal, B; Bajaj, A; Gupta, S; Gupta, SK; Jain, D; Kumar, S; Kumar, Y; Mehta, D; Pal, G; Pal, S; Rajput, K; Ramu, VS; Rana, K; Rani, P; Saini, V | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
| Azadian, BS; Brown, EA; Davies, SP; Kox, WJ | 1 |
| Bailey, EM; Kaatz, GW; Lamp, KC; Rybak, MJ; Seo, SM | 1 |
| Callegan, MC; Hill, JM; Hobden, JA; Insler, MS; O'Callaghan, RJ | 2 |
| Goto, S; Kaneko, Y; Miyazaki, S | 1 |
| Verbist, L; Verhaegen, J | 1 |
| Cooksey, RC; Facklam, RR; Gordon, S; Hill, BC; Jarvis, WR; Pigott, NE; Swenson, JM; Tenover, FC; Thornsberry, C | 1 |
| Altay, G; Cokça, F | 1 |
| Lenz, W; Machka, K; Milatovic, D; Voss, A | 1 |
| Durkovic, P; Fuchsberger, P; Korec, S; Koza, I; Krcméry, V; Kusenda, Z; Spanik, S; Sufliarsky, J; Svec, J; Trupl, J | 1 |
| Bailie, GR; Eisele, G | 1 |
| Dunne, WM; Henrickson, KJ | 1 |
| Adams, K; Calhoun, J; Cierny, G; Couch, L; Mader, JT | 1 |
| Baglin, TP; Marcus, RE; Warren, RE; Wimperis, JZ | 1 |
| Brumfitt, W; Hamilton-Miller, JM; Maple, PA | 1 |
| Auckenthaler, R; Chuard, C; Herrmann, M; Lew, DP; Lucet, JC; Rohner, P; Waldvogel, FA | 1 |
| Denyer, SP; Finch, RG; Smith, DG; Wilcox, MH; Williams, P | 1 |
| Barnass, S; Holland, K; Tabaqchali, S | 1 |
| Bouchenaki, N; Huggler, E; Lew, DP; Vaudaux, PE; Waldvogel, FA | 1 |
| Auckenthaler, R; Herrmann, M; Lew, DP; Lucet, JC; Rohner, P; Waldvogel, FA | 1 |
| Bint, AJ; George, JC; Orr, KE; Stansfield, E; Tapson, JS; Ward, MK | 1 |
| Barrett, A; Bennett-Jones, DN; Russell, GI | 1 |
| Fraise, AP; Friedland, JS; Iveson, TJ; Oliver, DO; Selkon, JB; Winearls, CG | 1 |
| Dworkin, R; Kunz, S; Modin, G; Rich, R; Sande, M; Zak, O | 1 |
| Edwards, R; Filik, R; Finch, RG; Wilcox, MH | 1 |
| Mazzei, T; Mini, E; Novelli, A; Periti, P | 1 |
| Lentino, JR; Strodthman, R | 1 |
| Liu, C; Stratton, CW; Weeks, LS | 1 |
| Liu, C; Ratner, HB; Stratton, CW; Weeks, LS | 1 |
| Bouanchaud, DH; Huet, Y; Rolin, O | 1 |
| Guay, D; Klicker, R; Pence, T; Peterson, P | 1 |
| Gruninger, R; Guay, DR; Gustilo, RB; Peterson, PK; Tsukayama, DT; Wicklund, B | 1 |
| Joly, P; Van der Auwera, P | 1 |
| DiVincenzo, CA; O'Keefe, JP; Tatarowicz, W; Venezio, FR | 1 |
| Gottschall, S; Kim, MJ; Randall, EL; Weiser, M | 1 |
| Claeys, G; Van den Abeele, AM; Verschraegen, G | 1 |
| Armynot du Chatelet, AM; Attisso, MA; Maillols, M; Simeon de Buochberg, M; Zuccarelli, M | 1 |
| Attisso, MA; Dusart, G; Maillols, H; Simeon de Buochberg, M; Zuccarelli, M | 1 |
| Cancet, B; Clave, D; Didier, J; Henry-Ferry, S; Marty, N | 1 |
| Fuursted, K | 1 |
| Eng, RH; Smith, SM | 1 |
| Falkiner, FR; Jones, L; Keane, CT; Mooney, D; Moorhouse, EC; Mulvihill, TE | 1 |
| Matthews, J; Newsom, SW; Rampling, AM | 1 |
| Fernandez-Guerrero, M; Henry, N; Rouse, M; Wilson, W | 1 |
| Barry, AL | 1 |
| Farrell, ID; Geddes, AM; Leyland, MJ; Smith, GM | 1 |
| Barriere, SL; Fekety, R; Kaatz, GW; Schaberg, DR | 3 |
| Finch, R; Martin, J; Pilkington, R | 1 |
| Floyd-Reising, SA; Hindler, JA; Kelley, SG; Young, LS | 1 |
| Barry, AL; Jones, RN | 1 |
| Henry, NK; McConnell, ME; Rouse, MS; Whitesell, AL; Wilson, WR | 1 |
| DiVincenzo, C; Foster, JK; Lentino, JR; Strodtman, R | 1 |
| Paton, JH; Williams, EW | 1 |
| Klastersky, J; Van der Auwera, P | 1 |
| Cagni, A; Chuard, C; Lew, DP; Schrenzel, J; Vaudaux, PE | 1 |
| Hryniewicz, W; Trzciński, K; Tyski, S; Zareba, T | 1 |
| Bohnen, JM; Burnett, RJ; Dellinger, EP; Haverstock, DC; Reinhart, HH; Rotstein, OD; Solomkin, JS; Vogel, SB | 1 |
| Erlendsdóttir, H; Gottfredsson, M; Gudmundsson, A; Gudmundsson, S | 1 |
| Bause, H; Höver, S; Scholz, J; Schulz, M; Steinfath, M | 1 |
| Caillon, J; Drugeon, HB; Juvin, ME | 1 |
| Cooper, B; Freeman, C; Mazens-Sullivan, M; Nightingale, C; Quintiliani, R; Robinson, A | 1 |
| Bruce, AW; Busscher, HJ; Cuperus, PL; Khoury, AE; Noordmans, J; Reid, G; van der Kuijl-Booij, M; Van der Mei, HC | 1 |
| Appelbaum, PC; Jacobs, MR; Pankuch, GA | 1 |
| Bourget, P; Clapeau, G; Hamon, M; Minosio, JP; Rieutord, A | 1 |
| Broeders, PH; Goessens, WH; Michel, MF; Schmal-Bauer, WC; Thompson, J; Voorn, GP | 1 |
| Bayston, R; Cave, CT; Clarke, H; Gaskin, PR; Levett, PN; StJohn, MA | 1 |
| Kaiser, AB; Kernodle, DS | 1 |
| Gilbert, C; Hussein, A; Meisenberg, B; Perfect, J; Peters, WP; Ross, M; Vredenburgh, J | 1 |
| Landman, D; Mobarakai, N; Quale, JM | 1 |
| Berlin, OG; Bruckner, DA; Helm, CJ; Holland, GN; Lin, R | 1 |
| Johnson, CC; Levison, ME; Livornese, LL; Osborne, AJ; Pitsakis, PG; Whitman, MS; Zausner, A | 1 |
| Day, CA; Day, DF; Marceau-Day, ML | 1 |
| McDonald, GR | 1 |
| Flokowitsch, J; Mullen, DL; Nicas, TI; Preston, DA; Unal, S | 1 |
| Capdevila, JA; Martínez-Vázquez, JM; Pahissa, A; Piera, L; Planes, AM; Ramírez-Arellano, M; Segarra, A | 1 |
| Henrickson, KJ; Sheth, KJ | 1 |
| Aristimuño, B; Hemady, RK; Nirankari, VS; Rodrigues, MM | 1 |
| Maskin, SL | 1 |
| Gibson, SP; Hawkins, JB; Manji, MR; Nwosu, AC; Nye, KJ; Robinson, BH | 1 |
| Ena, J; Houston, A; Jones, RN; Wenzel, RP | 1 |
| Grøndahl, TO; Langmoen, IA | 1 |
| Eng, RH; Ng, K; Smith, SM | 1 |
| Alamo, I; González, A | 1 |
| Hayden, MK; Matushek, MG; Trenholme, GM | 1 |
| Daoud, EG; Flexner, C; Goodman, SN; Hartert, TV; Heldman, AW; Kowalski, TE; Lietman, PS; Petty, BG; Pompili, VJ; Ray, SC; Sisson, SD; Tidmore, WC; vom Eigen, KA | 1 |
| Blecker, DL; Ferraro, AL; Mortensen, JE; Phengvath, C | 1 |
| Veis, JH; Vijayvargiya, R | 1 |
| Avalos, B; Biggs, J; Brodsky, I; Copelan, E; Crilley, P; Downs, K; Marks, DI; Moul, J; Penza, S; Sabol, P; Styler, MJ; Szer, J; Topolsky, D | 1 |
| Alfaro, DV; Bevin, AA; Hudson, SJ; Laughlin, RM; Mines, M; offele, JJ; Schoderbek, RJ | 1 |
| Branley, J; Gottlieb, T; Wolfson, C | 1 |
| Borderas, F; Delgado, J; Gallardo, JA; Leal, M; Lissen, E; Macías, J; Pineda, JA; Sánchez-Quijano, A | 1 |
| Garcia, R; Raad, I | 1 |
| Borner, K; Eckhardt, A; Keller, F; Zellner, D | 1 |
| Cartwright, K; Dooley, J; Fairclough, P; Mani, V; Oakley, C; Swarbrick, E | 1 |
| Archibald, L; Gaynes, R; McGowan, JE; Monnet, D; Phillips, L; Tenover, F | 1 |
| Sakamoto, M | 1 |
| Deobaldia, J; Evans, PA; Norden, CW; Rhoads, S; Silber, JL | 1 |
| Andriole, VT; Dembry, LM; Farrel, PA; Gerrity, LA; Orcutt, DR | 1 |
| Maskell, JP; Rafay, AM; Sefton, AM; Whiley, A; Williams, JD | 1 |
| Entenza, JM; Glauser, MP; Moreillon, P; Vouillamoz, J | 2 |
| Baraia-Etxaburu, J; Cisterna, R; Malero, P; Muñoz, J; Santamaría, JM; Teira, R; Unzaga, MJ | 1 |
| Degener, JE; Kosterink, JG; Mulder, JG | 1 |
| Hykin, P; Lightman, S; Matheson, M; Okhravi, N; Towler, HM | 1 |
| Gigi, J; Goffin, E; Pouthier, D; van Ypersele de Strihou, C; Vandercam, B | 1 |
| Canawati, HN; Montgomerie, JZ; Schick, DG | 1 |
| Chen, SN; Lee, KK; Liu, PC | 1 |
| Chankova, D; Guirguitzova, B; Minkov, N; Zozikov, B | 1 |
| Ananthakrishna, NC; Bhat, KG; Paul, C | 1 |
| Blatter, M; Frei, R; Ochsner, PE; Widmer, AF; Zimmerli, W | 1 |
| Burke, JP; Classen, DC; Ford, CD; Reilly, W; Wood, J | 1 |
| Hoban, DJ; Karlowsky, JA; Zhanel, GG | 1 |
| Bompart, F; Dowzicky, M; Feger, C; Nadler, HL; Pease, M; Talbot, G | 1 |
| Andremont, A; Guy, H; Marie, JP; Pico, JL; Richet, H; Vekhoff, A | 1 |
| Betts, RF; Blair, EA; Flesher, WR; Griggs, JJ; Norton, JR; Rowe, JM | 1 |
| Grudinina, SA; Krotova, LA; Rezvan, SP; Sidorenko, SV; Sterkhova, GV | 1 |
| Gorman, SP; Murphy, PG; Nixon, JR; Patrick, S; Ramage, G; Tunney, MM | 1 |
| Heisig, P; Jones, ME; Klootwijk, M; Schmitz, FJ; Verhoef, J; Visser, MR | 1 |
| Harris, AA; Hayden, MK | 1 |
| Dart, JK; Horgan, SE; Matheson, MM; McLOUGHLIN-Borlace, L | 1 |
| Filka, J; Huttova, M; Kralinsky, K; Krcmery, V; Sagat, T; Tuharsky, J | 1 |
| Albanèse, J; Arnaud, S; Cambon, S; Miliani, Y; Rossi, P | 1 |
| Bergh, K; Løseth, K; Persen, L; Witsø, E | 1 |
| Axtell, RA; Henrickson, KJ; Hoover, SM; Kehl, SC; Klein, JP; Kuhn, SM; Pritchett, J | 1 |
| Orrett, FA | 1 |
| Hsueh, PR; Hung, CC; Jang, TN; Lu, PL; Luh, KT; Teng, LJ | 1 |
| Eckert, SJ; McNeeley, DF; Noel, GJ | 1 |
| Fridkin, SK; Gaynes, RP; Hubert, SK; Lawton, R; McGowan, JE; Steward, CD; Tenover, FC; Wallace, D | 1 |
| Barchiesi, F; Cirioni, O; Giacometti, A; Scalise, G | 1 |
| Bandera, A; Degli Esposti, A; Ferrario, G; Franzetti, F; Gori, A; Marchetti, G; Rossi, MC; Tocalli, L | 1 |
| Duch, JM; Yee, J | 1 |
| Basso, M; Costa, SF; Levin, AS; Newbaer, M; Santos, CR; Soares, I | 1 |
| Dieleman, LA; Freitag, R; Li, F; Linde, HJ; Rath, HC; Sartor, RB; Schölmerich, J; Schultz, M | 1 |
| Araj, GF; Zouain, MG | 1 |
| Domínguez, L; Fernández-Garayzábal, JF; Latre, MV; Moreno, MA; Rodríguez, AA; Vela, AI | 1 |
| Capdevila, JA; Fortea, J; Gavaldà, J; Gomis, X; López, P; Martin, MT; Pahissa, A | 1 |
| Abu El-Asrar, AA; Kadry, AA; Shibl, AM; Tawfik, AF | 1 |
| Reid, CM; Wiadrowski, TP | 1 |
| Georgopoulos, A; Graninger, W; Grisold, A; Mueller-Uri, P; Presterl, E | 1 |
| Amorena, B; García-Alvarez, F; Gracia, E; Laclériga, A; Leiva, J; Monzón, M; Oteiza, C | 1 |
| Entenza, JM; Glauser, MP; Moreillon, P; Que, YA; Vouillamoz, J | 1 |
| Blanco, MT; Gómez-García, AC; Hurtado, C; Morán, FJ; Pérez-Giraldo, C; Sánchez-Silos, RM | 1 |
| Blandino, G; Caccamo, F; Milazzo, I; Musumeci, R; Nicoletti, G; Speciale, A | 1 |
| Baldursson, H; Gunnarsson, G; Hilmarsdottir, I | 1 |
| Edwards, JR; Fridkin, SK; Gaynes, RP; Hill, HA; Lawton, RM; McGowan, JE; Volkova, NV | 1 |
| Andresen, SW; Avery, RK; Bernhard, L; Bolwell, BJ; Goormastic, M; Kalaycio, ME; Kuczkowski, E; Longworth, DL; Mossad, SB; Ostendorf, H; Pohlman, BL; Sobecks, RM; Wise, K | 1 |
| Esber, E; Fogel, EL; Kalayci, C; Lehman, GA; Rerknimitr, R; Sherman, S | 1 |
| Apostol, S; Barbu, C; Filip, V | 1 |
| Grohs, P; Gutmann, L; Kitzis, MD | 1 |
| Gorman, SP; Nixon, JR; Patrick, S; Ramage, G; Tunney, MM | 1 |
| Mayayo Dehesa, T; Navas Elorza, E; Quereda Rodríguez-Navarro, C; Rodríguez-Patrón Rodríguez, R | 1 |
| Liu, J; Meng, QG; Wang, Q | 1 |
| Chan, RC; Cheng, AF; Cheung, SW; Hui, M; Kwok, AK; Lam, DS; Pang, CP | 1 |
| Aktaş, E; Ayyildiz, A; Ertek, M; Parlak, M; Yazgi, H | 1 |
| Domínguez, I; García Serrano, JL; Serrano Laborda, D | 1 |
| Cernohorská, L; Votava, M | 1 |
| Vedantham, V | 1 |
| Cieślikowski, T; Nowak, T; Rózalska, M; Szewczyk, EM | 1 |
| Greenberg, GR | 1 |
| Blevins, JS; Gustafson, JE; Langevin, MJ; O'Leary, JO; Price, CT; Smeltzer, MS | 1 |
| Palasuntheram, C; Perera, S | 1 |
| Agrappi, C; Clerici, P; Melloni, P; Vasconi, E; Viganò, EF | 1 |
| Abd-Allah, AR; Al-Suwayeh, SA; Bayomi, MA; Kadry, AA | 1 |
| Baker, SD; Horger, DC; Keane, TE | 1 |
| Nowakowska, M; Radosz-Komoniewska, H; Rudy, M; Wiechuła, B; Zientara, M | 1 |
| Aliprandis, E; Ciralsky, J; Herling, I; Katz, HR; Lai, H | 1 |
| Lehn, N; Linde, H | 1 |
| Jeyaratnam, D; Keenan, N; Sheerin, NS | 1 |
| Baek, DH; Chung, MJ; Ha, NJ; Kang, BY; Kang, JY; Kim, K; Kim, SD; Shin, EA; Yim, DS; Yun, JH | 1 |
| Cirioni, O; De Fusco, M; Ghiselli, R; Giacometti, A; Licci, A; Mocchegiani, F; Orlando, F; Provinciali, M; Saba, V; Scalise, G; Silvestri, C | 1 |
| Bacsal, K; Chee, SP | 1 |
| Balaban, N; Cirioni, O; Dell'Acqua, G; Ghiselli, R; Giacometti, A; Licci, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C | 1 |
| Eichhorn, E; Elz, S; Mahboobi, S; Möllmann, U; Popp, A; Sellmer, A | 1 |
| Almirante, B; Calleja, R; Fernandez-Hidalgo, N; Pahissa, A; Pigrau, C; Planes, AM; Rodriguez, D; Ruiz, I | 1 |
| Boger, MS; Collins, CA; Mason, L; Raad, II; Sherertz, RJ | 1 |
| Caniça, M; Dias, R; Louro, D | 1 |
| Arosey, A; Blanco, JR; Castilla, A; Ibarra, V; Morano, LE; Oteo, JA | 1 |
| Lipman, J; Roberts, JA | 1 |
| Anijeet, H; Corkill, JE; Parry, CM; Saxena, R; Taegtmeyer, M | 1 |
| Alvarez, FG; Amorena, B; García-Alvarez, F; García-Alvarez, I; Grasa, JM; Laclériga, A; Monzón, M; Navarro-Zorraquino, M | 1 |
| Blázquez, J; Fortún, J; García-San Miguel, L; Grill, F; Martín-Dávila, P; Moreno, S; Sánchez-Corral, J; Tato, M | 1 |
| Chen, WL; Chen, YM; Han, JH; Hu, FR; Su, PY | 1 |
| Kitiyakara, C; Likittanasombat, K; Lothuvachai, T; Milindankura, S; Sakulsaengprapha, A | 1 |
| Li, JT; Markus, P; Matesic, D; Park, M | 1 |
| Randleman, JB; Woodward, M | 1 |
| Adams, CS; Antoci, V; Hickok, NJ; Parvizi, J; Shapiro, IM | 1 |
| Blanchemain, N; Chai, F; Descamps, M; Hildebrand, HF; Hornez, JC; Neut, C | 1 |
| Boyle, JR; Chaudhuri, A; Gaunt, ME; Hayes, PD; Sadat, U; Varty, K | 1 |
| Arechavala, AI; Bianchi, MH; González, G; Maiolo, E; Negroni, R; Orduna, T; Santiso, G | 1 |
| Akhtar, M; Anderson, JF; Hirt, H; Parrish, TD; Zurek, L | 1 |
| Becket, E; Bui, A; Hong, J; Kim, K; Liu, A; Miller, JH; Sitz, D; Solaimani, P; Tamae, C; Tran, KP; Yang, H | 1 |
| Carter, JE; Mizell, KN; Patterson, KV | 1 |
| Blanchemain, N; Chai, F; Haulon, S; Hildebrand, HF; Kirkpatrick, CJ; Krump-konvalinkova, V; Laurent, T; Martel, B; Morcellet, M; Neut, C | 1 |
| Barralet, JE; Gbureck, U; Hofmann, MP; Mohammed, AR; Perrie, Y | 1 |
| Ahmad, A; Bhandari, A; Henry, A; Marchin, GL; Nagulapally, SR; Zurek, L | 1 |
| Cantore, SA; Delgado, A; Dueñas, S; Gustafson, JE; Horan, S; Lamichhane-Khadka, R; Norman, AE; Riordan, JT; Wilkinson, BJ; Zaman, S | 1 |
| Chai, F; Descamps, M; Hildebrand, HF; Hornez, JC; Leprêtre, S; Martel, B; Neut, C; Vermet, G | 1 |
| Arhin, FF; Huggler, E; Lew, DP; Moeck, G; Renzoni, A; Vaudaux, P | 1 |
| Bossaer, JB; Garrett-Mayer, E; Hall, PD | 1 |
| Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Shanks, RM | 1 |
| Banaszkiewicz, A; Młynarczyk, G; Obuch-Woszczatyński, P; Pituch, H; Radzikowski, A; Wultańska, D | 1 |
| Das, A; Ray, P; Sharma, M; Singh, R | 1 |
| Cleveland, KO; Mazumder, SA | 1 |
| Blanchemain, N; Chai, F; Flament, MP; Hildebrand, HF; Hoang Thi, TH; Leprêtre, S; Martel, B; Siepmann, F; Siepmann, J | 1 |
| Chakraborty, A; Gloriani, NG; Miyahara, S; Villanueva, SY; Yoshida, S | 1 |
| Bournakis, E; Christoulas, D; Dimopoulos, MA; Efstathiou, E; Eleutherakis-Papaiakovou, E; Gavriatopoulou, M; Kastritis, E; Kostis, E; Migkou, M; Papadimitriou, CA; Roussou, M; Terpos, E | 1 |
| Bierbaum, G; Jansen, A; Nagel, M; Reuter, T; Szekat, C | 1 |
| Enam, SA; Hassan, RU; Tahir, MZ | 1 |
| Balbir-Gurman, A; Bergman, R; Braun-Moscovici, Y; Egozi, D; Markovits, D; Melamed, Y; Ramon, Y; Rozin, AP; Schapira, D; Toledano, K; Ullman, Y | 1 |
| Barshikar, S; Baylor, AE; Dolman, HS; Glowniak, J; Hong, K; Lavery, T; Nailor, M; Singla, R; Stassinopoulus, J; Tyburski, JG; Wilson, RF; Zimmerman, LH | 1 |
| Diaz-Guzman, E; Hayes, D; Hoopes, CW | 1 |
| Choi, JG; Han, SH; Kang, OH; Keum, JH; Kim, SB; Kim, YG; Kwon, DY; Lee, JH; Mun, SH; Obiang-Obounou, BW; Park, CB; Shin, DW | 1 |
| Alış, EE; Cengiz, M; Ekici, S; Turan, G | 1 |
| Del Campo, R; López, M; Tenorio, C; Torres, C; Zarazaga, M | 1 |
| Fajardo Olivares, M; Hidalgo Orozco, R; Robles Marcos, M; Rodríguez Garrido, S; Rodríguez-Vidigal, FF; Vera Tomé, A | 1 |
| Abrishami, M; Gharaee, H; Khalife, M; Poor, SS | 1 |
| Alliot, F; Chevreuil, M; Dinh, QT; Eurin, J; Labadie, P; Moreau-Guigon, E | 1 |
| Damasceno, QS; de Oliveira, AC; Nicoli, JR; Piscoya, M | 1 |
| Eriguchi, Y; Harada, Y; Kadowaki, M; Miyake, N; Nagasaki, Y; Sato, Y; Shimono, N; Uchida, Y | 1 |
| Blanchemain, N; Haulon, S; Hildebrand, HF; Jean-Baptiste, E; Martel, B; Neut, C | 1 |
| Dosler, S; Gerceker, AA | 1 |
| Ergun, H; Köseoglu-Eser, O; Mamuk, S; Melli, M; Saribas, Z | 1 |
| Holodniy, M; Lucero, CA; Mercier, RC; Nguyen, N; Oda, G; Ryono, RA; Schirmer, PL | 1 |
| Hooper, CY; Khan, A; Lightman, SL; Pacheco, P; Tam, PM; Taylor, SR | 1 |
| Bellomo, R; Cole, L; Lipman, J; Liu, X; Nair, P; Roberts, DM; Roberts, JA; Roberts, MS | 1 |
| Ezoe, T; Ishiyama, M; Matsumoto, K; Noguchi, K; Shiga, M; Suenaga, H; Tsukatani, T | 1 |
| Basualdo, J; Bernstein, J; De Luca, M; Delpech, G; Grenovero, S; Pourcel, G; Schell, C; Sparo, M | 1 |
| Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Parshin, VD; Vishnevskaia, GA | 1 |
| Degener, JE; Feik, D; Mortensen, JE; Rams, TE; van Winkelhoff, AJ | 1 |
| Ben Slama, K; Ben Slimen, N; Boudabous, A; Daffonchio, D; Fhoula, I; Klibi, N; López, M; Ouzari, H; Torres, C | 1 |
| Bonomo, RA; Donskey, CJ; Drawz, PE; Hirsch, AA; Jump, RL; Jury, LA; Kypriotakis, G; Olds, DM; Peron, EP; Seifi, N; Watts, B | 1 |
| Mehta, J; Pi, J; Trifilio, SM | 1 |
| Abriouel, H; Benomar, N; Gálvez, A; Lavilla Lerma, L; Pérez Pulido, R; Sánchez Valenzuela, A | 1 |
| Bojarska, A; Gawryszewska, I; Hryniewicz, W; Malinowska, K; Sadowy, E; Sieńko, A | 1 |
| Haque, N; Hoque, SM; Hossain, MA; Kabir, MR; Paul, SK; Rahman, A; Sultana, S | 1 |
| Adamidou, F; Anagnostis, P; Karras, S; Kita, M | 1 |
| Mansouri, S; Sadeghi, J | 1 |
| Gounari, P; Kougias, M; Sioula, E; Skourtis, A; Vallianou, N | 1 |
| Drew, RJ; Paulus, S | 1 |
| Cars, O; Forsberg, P; Giske, CG; Hickman, RA; Lagerbäck, P; Tängdén, T | 1 |
| Fortier, LC; Garneau, JR; Valiquette, L | 1 |
| Avutu, V; Cao, X; Flynn, PM; Gaur, AH; Hayden, RT; Howard, SC; Inaba, H; Marszal, LN; Pounds, SB; Pui, CH; Ribeiro, RC; Rubnitz, JE | 1 |
| Covens, L; Echahidi, F; François, K; Piérard, D; Pipeleers, L; Wybo, I; Yusuf, E | 1 |
| Han, W; Hornyák, I; Horváthy, DB; Kalugyer, P; Lacza, Z; Madácsi, E; Szendrői, M; Vácz, G | 1 |
| Dörries, K; Lalk, M; Schlueter, R | 1 |
| Ahmed, A; Naz, S; Saied, S; Shahid, SM | 1 |
| Bowler, IC; Buchanan, R; Crook, D; Stoesser, N | 1 |
| de Haller, R; Mavrakanas, TA; Philippe, J | 1 |
| Climente, M; Martínez-Moreno, J; Merino, V; Merino-Sanjuán, M; Mura, C; Nácher, A | 1 |
| Avery, LM; Weiss, E; Zempel, M | 1 |
| Buyck, JM; Peyrusson, F; Tulkens, PM; Van Bambeke, F | 1 |
| Andersen, ML; Hougaard, AB; Ingmer, H; Paulander, W; Skibsted, LH; Wang, Y | 1 |
| Amemoto, Y; Aoyama, T; Arakawa, S; Deguchi, T; Egawa, S; Fujimoto, Y; Fujisawa, M; Goto, H; Hamasuna, R; Hanaki, H; Hashimura, T; Hayami, H; Hirose, T; Ichikawa, T; Inatomi, H; Ishihara, S; Ishikawa, K; Ishitoya, S; Ito, N; Ito, T; Iwata, S; Kadota, J; Kagara, I; Kaku, M; Kanamaru, S; Kato, M; Kawanishi, H; Kimura, T; Kiyota, H; Kobayashi, K; Kobuke, M; Koda, S; Komeda, H; Kumon, H; Kunishima, Y; Maeda, H; Matsubara, A; Matsuda, Y; Matsui, T; Matsukawa, M; Matsumoto, M; Matsumoto, T; Minamitani, S; Mita, K; Mitsumori, K; Muranaka, T; Nakamura, I; Nishimura, K; Oka, H; Okumura, K; Onishi, H; Onodera, S; Sato, J; Shigeta, M; Sunakawa, K; Taguchi, K; Takahashi, K; Takahashi, S; Takahashi, Y; Takenaka, T; Tanaka, K; Togo, Y; Tsugawa, M; Tsukamoto, T; Uehara, S; Wakeda, H; Watanabe, A; Yamada, D; Yamamoto, S; Yamashita, M; Yasuda, M | 1 |
| Bedenić, B; Godič Torkar, K; Plečko, V | 1 |
| Dan, LA; Lim, RL; Ngu, DY; Ooi, A; Wong, A | 1 |
| Altboum, Z; Bar-David, E; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S | 1 |
| Azzam, O; Crowe, A; Pawar, B; Sajiv, C | 1 |
| Busscher, HJ; Daghighi, S; Dijkstra, RJ; Harapanahalli, A; Sjollema, J; van der Mei, HC | 1 |
| Camacho-Ortiz, A; Casillas-Vega, N; Garza-González, E; González, GM; Llaca-Díaz, J; Mendoza-Olazarán, S; Morfín-Otero, R; Rodríguez-Noriega, E; Villarreal-Treviño, L | 1 |
| Barnett, AG; Diab, S; Fraser, JF; Fung, YL; Roberts, JA; Shekar, K; Wallis, SC | 1 |
| D'Souza, S; Kang, TM; Lam, K; Miller, JH; Song, LY; Yeh, P | 1 |
| Behrooz, MJ; Sheibani, K; Soleimani, M; Tabatabaei, SA | 1 |
| Kidenya, BR; Mirambo, MM; Moremi, N; Mshana, SE; Okamo, B; Seni, J | 1 |
| Ahn, JW; Baek, YS; Jeon, J; Song, HJ | 1 |
| Al-Dahir, S; Brakta, F; Gillard, CJ | 1 |
| Belzer, C; Cranendonk, DR; de Vos, AF; de Vos, WM; Lankelma, JM; van der Poll, T; Wiersinga, WJ | 1 |
| Desai, S; Nair, S; Poonacha, N; Sharma, U; Vipra, A | 1 |
| Kriz, Z; Krutova, M; Kubicek, L; Kuijper, E; Matejkova, J; Nyc, O; Ruzicka, F; Tejkalova, R | 1 |
| Goto, M; Hara, H; Iwamoto, K; Othman, NB; Sugiura, N; Utsumi, M; Yusaimi, YA; Zakaria, Z; Zulkeflle, SNM | 1 |
| Atci, E; Beyenal, H; Call, DR; Kiamco, MM; Mohamed, A | 1 |
| Guo, H; Kwok, L; Li, L; Lu, J; Menghe, B; Pan, L; Zhang, H; Zhang, W | 1 |
| Hsieh, TC; Hsueh, PR; Jean, SS; Ning, YZ | 1 |
| Maxson, T; Minogue, TD; Taylor-Howell, CL | 1 |
| Bayston, R; Belfield, K; Birchall, JP; Daniel, M; Hajduk, N; Levell, G | 1 |
| Gow, P; Hey, P; Johnson, P; Lokan, J | 1 |
| Chansiw, N; Chotinantakul, K; Okada, S | 1 |
| Lukenge, M; Mboowa, G; Mwambi, B; Segujja, F; Sserwadda, I; Walusimbi, A | 1 |
| Rabadi, MH | 1 |
| Aliramezani, A; Baghani, A; Douraghi, M; Ghourchian, S; Mesdaghinia, A; Yaseri, M | 1 |
| Holmes, E; Keiser, J; Li, JV; Liu, Z; Saric, J; Utzinger, J; Xia, B | 1 |
| Blaskovich, MAT; Cooper, MA; Gong, Y; Kavanagh, A; Ramu, S | 1 |
| Kakkos, SK; Papadoulas, SI | 1 |
| Belzer, C; de Vos, WM; Haak, BW; Hugenholtz, F; Lankelma, JM; Wiersinga, WJ | 1 |
| Bae, IG; Cho, OH; Choi, SH; Chong, YP; Kang, KC; Kim, DY; Kim, SH; Kim, YS; Lee, JH; Lee, MS; Lee, SO; Lee, YM; Moon, C; Park, KH; Park, SY; Ryu, BH; Woo, JH | 1 |
| Chen, PX; Fu, JL; Gu, XX; Jiang, HX; Yang, L; Zhang, LJ | 1 |
| Goffin, E; Jacques, N; Lancellotti, P; Musumeci, L; Oury, C; Pirotte, B; Servais, L | 1 |
| Awad, AR; Elawady, BA; ElFeky, DS; Elshobaky, MA | 1 |
| Epps, KL; Epps, QJ; Young, DC; Zobell, JT | 1 |
| Uskoković, V | 1 |
| Averick, S; Cheng, BC; Eutsey, R; Hiller, L; Payne, C; Tomycz, ND; Whiting, DM | 1 |
| Ayyala, RS; Blake, DA; Sahiner, N; Suner, SS; Zhang, Z | 1 |
| Kheng, C; Ling, CL; Miliya, T; Reed, TAN; Roberts, T; Tan, P; Turner, P; Watson, G | 1 |
| Díaz Barrón, A; Duch-Samper, AM; Hervás Hernandis, JM; Sanz Gallen, L; Tarragó Simón, E | 1 |
| Cheng, JW; Fan, X; Hou, X; Kudinha, T; Liang, GW; Liu, C; Shao, DH; Su, JR; Wang, Y; Wei, M; Xiao, M; Xiong, ZJ; Xu, YC; Yang, CX; Yang, QW; Yu, SY | 1 |
| Almuwallad, OK; Barnawi, AI; Kassarah, KA; Kordy, FN | 1 |
| Hiramatsu, K; Hishinuma, T; Kirikae, T; Matsuo, M; Morimoto, Y; Sasaki, T; Singh, M; Yamamoto, N | 1 |
| Czuczwar, M; Jaroszewski, J; Nosek, K; Onichimowski, D; Pawlos, A; Ziółkowski, H | 1 |
| Bastiaanssen, TFS; Cryan, JF; Dinan, TG; Fitzgerald, P; Fulling, C; Moloney, GM; O'Connor, R; O'Riordan, KJ; Schellekens, H | 1 |
| Dos Santos, LDR; Furlan, JPR; Gallo, IFL; Ramos, MS; Savazzi, EA; Stehling, EG | 1 |
| Campos Mollo, E; Matarredona Muñoz, J; Moya Roca, J; Porcar Plana, CA | 1 |
| Rosman, CWK; Sjollema, J; van der Mei, HC | 1 |
| Hou, JY; Huang, HM; Huang, TH; Liu, HC; Lu, CH; Sun, FJ; Yeh, TC | 1 |
| Das, S; Gunasekaran, R; Mitra, S; Mohamed, A; Prajna, L; Prajna, NV; Sharma, S; Soni, T | 1 |
| Abiri, R; Alvandi, A; Fathollahi, M; Kadivarian, S; Motamedi, H; Rostamian, M | 1 |
| Cheng, X; Guan, M; Jolkkonen, J; Lin, X; Liu, C; Liu, F; Liu, Z; Wang, Y; Xiao, T; Zhao, C; Zhao, Y; Zhong, S | 1 |
| Aguado, JM; Silva, JT | 1 |
| Allen, L; Bartash, R; Cowman, K; Fauvel, D; Guo, Y; Minamoto, GY; Nnani, DU; Patel, S; Vukelic, S | 1 |
| Pintarić, S; Štritof, Z; Tumpa, A | 1 |
| Ali, MM; Ijaz, M; Muzammil, I; Saleem, MH | 1 |
| Abdulla, A; Bos, K; de Winter, BCM; Koch, BCP; Muller, AE; Oosterhoff, M; van Oldenrijk, J; Zhao, Q | 1 |
| Fan, X; Kang, X; Luo, S; Luo, X; Wang, G; Wei, Y; Zhao, S | 1 |
| Hryniewicz, W; Sadowy, E; Wardal, E; Żabicka, D | 1 |
| Chang, SC; Hidrosollo, JH; Kao, CY; Lin, LC; Lu, JJ; Ou, YH | 1 |
| Cristino, S; Girolamini, L; Grottola, A; Mazzotta, M; Orsini, M; Pascale, MR; Salaris, S; Zini, N | 1 |
| Mishra, V; Ojha, AK; Shah, NP | 1 |
| Bartoszewicz, M; Brożyna, M; Dudek-Wicher, R; Dydak, K; Junka, A; Madziała, M; Oleksy-Wawrzyniak, M; Paleczny, J | 1 |
| Abdul Ameer Al-Kraety, I; Ghani Al-Muhanna, S; Maki N Al-Muaala, A; Sadeq Yasir Al-Ethari, A | 1 |
| Abdollahi, N; Alebouyeh, M; Armin, S; Attaran, B; Azimi, L; Behzad, A; Fahimzad, SA; Fallah, F; Ghanaiee, RM; Ghandchi, G; Gholinejad, Z; Hassanzadeh, R; Karimi, A; Mahdavi, A; Safarkhani, A; Sheikhi, Z; Shirvani, F; Tabatabaei, SR | 1 |
17 review(s) available for vancomycin and ciprofloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Drug Discovery; Humans; Microbial Sensitivity Tests; Molecular Conformation; Tetracyclines | 2016 |
Antibacterial activity study of 1,2,4-triazole derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2019 |
Chemically Tuning Resveratrol for the Effective Killing of Gram-Positive Pathogens.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Resveratrol | 2022 |
Continuous ambulatory peritoneal dialysis: a review of its mechanics, advantages, complications, and areas of controversy.
Topics: Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Renal Dialysis; Technology Assessment, Biomedical; Vancomycin | 1992 |
Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clinical Trials, Phase III as Topic; Drug Resistance, Multiple; Enterococcus faecium; Gram-Positive Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus epidermidis; Vancomycin; Virginiamycin | 1998 |
Confronting antibiotic resistance in enterococcal infections.
Topics: Aminoglycosides; beta-Lactam Resistance; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Drugs, Investigational; Enterococcus; Gram-Positive Bacterial Infections; Humans; Vancomycin | 1994 |
Antibiotics should be used as first-line therapy for Crohn's disease.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Crohn Disease; Humans; Imipenem; Metronidazole; Time Factors; Treatment Outcome; Vancomycin | 2004 |
[Endocarditis due to Bartonella spp. Three new clinical cases and Spanish literature review].
Topics: Actinobacillus Infections; Adult; Aged; Aggregatibacter actinomycetemcomitans; Alcoholism; Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Aortic Valve; Bartonella henselae; Bartonella Infections; Blood; Cardiomyopathy, Hypertrophic; Cat-Scratch Disease; Cats; Ceftriaxone; Chlamydia; Ciprofloxacin; Combined Modality Therapy; Disease Susceptibility; Doxycycline; Endocarditis, Bacterial; Endocarditis, Subacute Bacterial; False Negative Reactions; Female; Gentamicins; Heart Valve Prosthesis Implantation; Humans; Male; Middle Aged; Spain; Vancomycin | 2006 |
Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactams; Ciprofloxacin; Critical Care; Drug Administration Schedule; Drug Monitoring; Humans; Sepsis; Vancomycin | 2006 |
Empyema necessitatis due to methicillin-resistant Staphylococcus aureus: case report and review of the literature.
Topics: Anti-Bacterial Agents; Blood; Ciprofloxacin; Empyema; Humans; Lung; Male; Methicillin Resistance; Middle Aged; Pneumonia; Radiography, Thoracic; Staphylococcal Infections; Staphylococcus aureus; Thorax; Trimethoprim, Sulfamethoxazole Drug Combination; Urine; Vancomycin; White People | 2008 |
Changing epidemiology of Clostridium difficile-associated disease during stem cell transplantation.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Aztreonam; Chicago; Ciprofloxacin; Clostridioides difficile; Enterococcus faecium; Enterocolitis, Pseudomembranous; Female; Graft vs Host Disease; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Risk Factors; Survival Rate; Transplantation, Homologous; Vancomycin; Vancomycin Resistance | 2013 |
Role of vancomycin in the treatment of bacteraemia and meningitis caused by Elizabethkingia meningoseptica.
Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Synergism; Drug Therapy, Combination; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Immunocompromised Host; Infant, Low Birth Weight; Infant, Newborn; Linezolid; Meningitis, Bacterial; Rifampin; Treatment Outcome; Vancomycin | 2017 |
State of the art in cystic fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Ciprofloxacin; Clindamycin; Cystic Fibrosis; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin-Resistant Staphylococcus aureus; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2020 |
Prevention of Implant-Associated Infection in Neuromodulation: Review of the Literature and Prototype of a Novel Protective Implant Coating.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Electric Stimulation Therapy; Glycerol; Humans; Prosthesis-Related Infections; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin | 2020 |
A worldwide systematic review and meta-analysis of bacteria related to antibiotic-associated diarrhea in hospitalized patients.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Chloramphenicol; Ciprofloxacin; Clostridioides difficile; Clostridium perfringens; Diarrhea; Humans; Klebsiella oxytoca; Metronidazole; Prevalence; Staphylococcus aureus; Vancomycin | 2021 |
The mysteries of target site concentrations of antibiotics in bone and joint infections: what is known? A narrative review.
Topics: Anti-Bacterial Agents; Cefazolin; Cefuroxime; Ciprofloxacin; Humans; Linezolid; Microbial Sensitivity Tests; Vancomycin | 2022 |
19 trial(s) available for vancomycin and ciprofloxacin
| Article | Year |
|---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
[Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany].
Topics: Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Fosfomycin; Germany; Humans; Imipenem; Methicillin; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1992 |
Ciprofloxacin plus vancomycin versus ceftazidime plus gentamicin in the treatment of pneumonia in granulocytopenic patients with or without venous catheters. Short communication.
Topics: Adult; Agranulocytosis; Bronchopneumonia; Catheterization; Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Gentamicins; Humans; Middle Aged; Pilot Projects; Vancomycin | 1992 |
A comparison between oral ciprofloxacin and intraperitoneal vancomycin and netilmicin in CAPD peritonitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ciprofloxacin; Female; Humans; Injections, Intraperitoneal; Male; Middle Aged; Netilmicin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Vancomycin | 1990 |
A comparison between oral ciprofloxacin and intra-peritoneal vancomycin and gentamicin in the treatment of CAPD peritonitis.
Topics: Administration, Oral; Adult; Ciprofloxacin; Gentamicins; Humans; Injections, Intraperitoneal; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Remission Induction; Vancomycin | 1990 |
A comparison between intraperitoneal ciprofloxacin and intraperitoneal vancomycin and gentamicin in the treatment of peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD).
Topics: Adult; Aged; Ciprofloxacin; Female; Gentamicins; Humans; Injections, Intraperitoneal; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1990 |
Definition of the role of enterococcus in intraabdominal infection: analysis of a prospective randomized trial.
Topics: Abscess; Adult; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Peritonitis; Prospective Studies; Sepsis; Treatment Failure; Vancomycin | 1995 |
Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Bone Marrow Purging; Bone Marrow Transplantation; Breast Neoplasms; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Injections, Intravenous; Middle Aged; Neutropenia; Rifampin; Stem Cell Transplantation; Tobramycin; Vancomycin | 1994 |
Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Endocarditis, Bacterial; Female; Gentamicins; Humans; Infusions, Intravenous; Length of Stay; Male; Oxacillin; Penicillins; Prospective Studies; Rifampin; Staphylococcal Infections; Substance Abuse, Intravenous; Treatment Outcome; Vancomycin | 1996 |
Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Humans; Peritoneal Dialysis; Peritonitis; Vancomycin | 1997 |
Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Disease-Free Survival; Double-Blind Method; Drug Therapy, Combination; Female; Floxacillin; Hip Prosthesis; Humans; Knee Prosthesis; Male; Middle Aged; Orthopedic Fixation Devices; Penicillins; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Treatment Outcome; Vancomycin | 1998 |
Oral antimicrobial prophylaxis in bone marrow transplant recipients: randomized trial of ciprofloxacin versus ciprofloxacin-vancomycin.
Topics: Antibiotic Prophylaxis; Bone Marrow Transplantation; Candidiasis; Ciprofloxacin; Drug Therapy, Combination; Humans; Staphylococcal Infections; Staphylococcus; Vancomycin | 1998 |
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Multivariate Analysis; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin | 1998 |
Ciprofloxacin plus piperacillin is an equally effective regimen for empiric therapy in febrile neutropenic patients compared with standard therapy.
Topics: Adult; Amphotericin B; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Neutropenia; Piperacillin; Prospective Studies; Time Factors; Vancomycin | 1998 |
Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial.
Topics: Anti-Infective Agents; Bacteremia; Catheterization, Central Venous; Child; Child, Preschool; Ciprofloxacin; Double-Blind Method; Female; Fibrinolytic Agents; Heparin; Humans; Immunocompromised Host; Infant; Male; Prospective Studies; Solutions; Thrombosis; Vancomycin | 2000 |
Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Blood; Catheterization, Central Venous; Catheters, Indwelling; Ciprofloxacin; Colony Count, Microbial; Cross Infection; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Heparin; Humans; Male; Middle Aged; Vancomycin | 2006 |
Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Fever; Graft Survival; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infections; Length of Stay; Neutropenia; Survival Rate; Transplantation, Autologous; Vancomycin | 2010 |
Effective antimicrobial stewardship in a long-term care facility through an infectious disease consultation service: keeping a LID on antibiotic use.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Ciprofloxacin; Clindamycin; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans; Infectious Disease Medicine; Long-Term Care; Nitrofurantoin; Nursing Homes; Referral and Consultation; Regression Analysis; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2012 |
Antibiotic-induced gut microbiota disruption during human endotoxemia: a randomised controlled study.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Drug Monitoring; Endotoxemia; Escherichia coli; Gastrointestinal Microbiome; Healthy Volunteers; Humans; Immunity, Innate; Klebsiella pneumoniae; Male; Metronidazole; Sepsis; Streptococcus pneumoniae; Treatment Outcome; Vancomycin | 2017 |
448 other study(ies) available for vancomycin and ciprofloxacin
| Article | Year |
|---|---|
Antibacterial diterpenes from Calceolaria pinifolia.
Topics: Animals; Anti-Bacterial Agents; Argentina; Bacillus subtilis; Diterpenes; Erythrocytes; Escherichia coli; Female; Humans; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Plants, Medicinal; Scrophulariaceae; Staphylococcus aureus | 2003 |
Synthesis and structure-activity relationships of 5-amino-6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-8-methylquinolonecarboxylic acid antibacterials having fluorinated 7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl] substituents.
Topics: Anti-Bacterial Agents; Cyclopropanes; Drug Resistance, Bacterial; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinolones; Stereoisomerism; Structure-Activity Relationship | 2003 |
Synthesis of substituted 6-anilinouracils and their inhibition of DNA polymerase IIIC and Gram-positive bacterial growth.
Topics: Aniline Compounds; Anti-Bacterial Agents; DNA Polymerase III; Enzyme Inhibitors; Gram-Positive Bacteria; Hydrophobic and Hydrophilic Interactions; Microbial Sensitivity Tests; Structure-Activity Relationship; Uracil | 2003 |
New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine.
Topics: Animals; Anti-Bacterial Agents; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Gram-Positive Bacteria; HeLa Cells; Humans; Lactams; Lactones; Mice; Microbial Sensitivity Tests; Models, Molecular; Oxadiazoles; Peptides, Cyclic; Protein Subunits; Staphylococcal Infections; Stereoisomerism; Structure-Activity Relationship; Topoisomerase II Inhibitors; Toxicity Tests | 2004 |
A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Clinical Trials, Phase I as Topic; Dogs; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Mutation; Prodrugs; Quinolizines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Vancomycin Resistance | 2005 |
Synthesis and antibacterial activity of 3-substituted-6-(3-ethyl-4-methylanilino)uracils.
Topics: Aniline Compounds; Animals; Anti-Bacterial Agents; DNA Polymerase III; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Uracil | 2005 |
Antibacterial, partially acetylated oligorhamnosides from Cleistopholis patens.
Topics: Annonaceae; Anti-Bacterial Agents; Gabon; Glycosides; Methicillin Resistance; Molecular Structure; Plant Leaves; Plants, Medicinal; Staphylococcus aureus | 2006 |
An oxidation-sensing mechanism is used by the global regulator MgrA in Staphylococcus aureus.
Topics: Bacterial Proteins; Cysteine; Hydrogen Peroxide; Oxidation-Reduction; Protein Conformation; Protein Structure, Tertiary; Repressor Proteins; Staphylococcus aureus | 2006 |
Influence on mitochondria and cytotoxicity of different antibiotics administered in high concentrations on primary human osteoblasts and cell lines.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Antimycin A; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cells, Cultured; Chloramphenicol; Clindamycin; Dose-Response Relationship, Drug; Fluoroquinolones; Glycolysis; HeLa Cells; Humans; Lactic Acid; Linezolid; Macrolides; Mitochondria; Osteoblasts; Oxazolidinones; Rotenone; Tetracyclines; Time Factors | 2007 |
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
Topics: Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Boston; Female; HIV Infections; Humans; Male; Methicillin Resistance; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome | 2007 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Isothiazoloquinolones with enhanced antistaphylococcal activities against multidrug-resistant strains: effects of structural modifications at the 6-, 7-, and 8-positions.
Topics: Animals; Anti-Bacterial Agents; Cell Line, Tumor; Drug Resistance, Multiple, Bacterial; Female; Humans; Methicillin Resistance; Mice; Quinolones; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles; Topoisomerase II Inhibitors | 2007 |
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles | 2007 |
In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Pyrrolidines; Quinazolinones; Topoisomerase II Inhibitors | 2007 |
Polyamine effects on antibiotic susceptibility in bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Polyamines; Spermine; Staphylococcus aureus | 2007 |
Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacterial Proteins; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Signal Transduction; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2007 |
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes; Vancomycin Resistance; Viridans Streptococci | 2007 |
Novel semisynthetic derivative of antibiotic Eremomycin active against drug-resistant gram-positive pathogens including Bacillus anthracis.
Topics: Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Drug Resistance, Bacterial; Glycopeptides; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship | 2007 |
Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.
Topics: Aged; Anti-Bacterial Agents; Canada; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Mupirocin; Staphylococcal Infections; Staphylococcus aureus | 2007 |
Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells.
Topics: Anti-Bacterial Agents; Cell Division; Ciprofloxacin; Daptomycin; Erythromycin; Gentamicins; Hydrazones; Microbial Sensitivity Tests; Nafcillin; Staphylococcus aureus; Vancomycin | 2007 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Effect of polysorbate 80 on oritavancin binding to plastic surfaces: implications for susceptibility testing.
Topics: Adsorption; Animals; Anti-Bacterial Agents; Bacterial Infections; Carbon Radioisotopes; Culture Media, Conditioned; Enterococcus; Glycopeptides; Horses; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Polysorbates; Radioligand Assay; Staphylococcus; Streptococcus; Surface Properties; Teicoplanin | 2008 |
First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Drug Resistance, Bacterial; Humans; Linezolid; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Oxazolidinones; Sequence Analysis, DNA; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro activity of telavancin against resistant gram-positive bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 2008 |
Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain.
Topics: Adult; Aged; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Community-Acquired Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Female; Hospitalization; Humans; Incidence; Male; Middle Aged; Prognosis; Quebec; Ribotyping; Risk Factors | 2008 |
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
Topics: Anti-Bacterial Agents; Antiporters; ATP-Binding Cassette Transporters; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin | 2008 |
Antibacterial profile against drug-resistant Staphylococcus epidermidis clinical strain and structure-activity relationship studies of 1H-pyrazolo[3,4-b]pyridine and thieno[2,3-b]pyridine derivatives.
Topics: Anti-Bacterial Agents; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Humans; Leukocytes, Mononuclear; Microbial Sensitivity Tests; Models, Molecular; Pyrazoles; Pyridines; Reference Values; Staphylococcus epidermidis; Structure-Activity Relationship; Time Factors | 2008 |
Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms.
Topics: Anti-Infective Agents; Biofilms; Bioreactors; Electricity; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis | 2009 |
Isolation of VanB-type Enterococcus faecalis strains from nosocomial infections: first report of the isolation and identification of the pheromone-responsive plasmids pMG2200, Encoding VanB-type vancomycin resistance and a Bac41-type bacteriocin, and pMG2
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Bacteriocins; Blotting, Southern; Conjugation, Genetic; Cross Infection; Culture Media; DNA Nucleotidyltransferases; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Erythromycin; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Perforin; Pheromones; Plasmids; Vancomycin Resistance | 2009 |
Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals.
Topics: Bacterial Proteins; China; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Hospitals, Teaching; Humans; Leukocidins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin-Binding Proteins; Staphylococcal Infections | 2009 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
Topics: Anti-Bacterial Agents; Asia; Drug Resistance, Bacterial; Europe; Gram-Positive Bacteria; Humans; Latin America; Microbial Sensitivity Tests; North America; Pacific Ocean; Quality Control; Teicoplanin; Vancomycin | 2009 |
Neopyrrolomycins with broad spectrum antibacterial activity.
Topics: Anti-Bacterial Agents; Crystallography, X-Ray; Drug Resistance, Bacterial; Drug Screening Assays, Antitumor; Enterococcus faecium; Escherichia coli; Humans; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Conformation; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Pseudomonas aeruginosa; Pyrroles; Streptococcus pneumoniae; Streptomyces; Vancomycin | 2009 |
Synthesis and in vitro activity of dicationic bis-benzimidazoles as a new class of anti-MRSA and anti-VRE agents.
Topics: Anti-Bacterial Agents; Benzimidazoles; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Structure-Activity Relationship; Vancomycin Resistance | 2009 |
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Europe; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hospitalization; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrimidines; Staphylococcus aureus; Streptococcus; United States | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Optimization of the central linker of dicationic bis-benzimidazole anti-MRSA and anti-VRE agents.
Topics: Anti-Bacterial Agents; Benzimidazoles; Cations; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pentamidine; Structure-Activity Relationship; Vancomycin Resistance | 2009 |
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
Topics: Anti-Bacterial Agents; Benzofurans; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enterobacteriaceae; Enterococcus; Microbial Sensitivity Tests; Moraxella catarrhalis; Pyrones; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae | 2009 |
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
Topics: Anti-Bacterial Agents; Azepines; Bacteria, Anaerobic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 2009 |
The synthesis and biological evaluation of a novel series of C7 non-basic substituted fluoroquinolones as antibacterial agents.
Topics: Anti-Bacterial Agents; Chemistry, Pharmaceutical; Ciprofloxacin; Drug Design; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Stereoisomerism; Streptococcus pneumoniae; Structure-Activity Relationship; Vancomycin | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Synthesis and structure-activity relationship of dicationic diaryl ethers as novel potent anti-MRSA and anti-VRE agents.
Topics: Anti-Bacterial Agents; Benzimidazoles; Enterococcus; Ethers; Indoles; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pentamidine; Phenyl Ethers; Structure-Activity Relationship; Vancomycin Resistance | 2009 |
Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains.
Topics: Animals; Anti-Bacterial Agents; Bacillus anthracis; Cell Death; Cell Line; Gram-Negative Bacteria; Gram-Positive Bacteria; Macrophages; Mice; Staphylococcus aureus; Yersinia pestis | 2009 |
Design, synthesis, and structure-activity relationships of benzophenone-based tetraamides as novel antibacterial agents.
Topics: Amides; Animals; Anti-Bacterial Agents; Benzophenones; Cell Membrane; Cell Wall; CHO Cells; Cricetinae; Cricetulus; DNA, Bacterial; Drug Design; Drug Resistance, Bacterial; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Protein Biosynthesis; RNA, Bacterial; Staphylococcus aureus; Structure-Activity Relationship | 2009 |
Discovery of Trp-His and His-Arg analogues as new structural classes of short antimicrobial peptides.
Topics: Antimicrobial Cationic Peptides; Bacteria; Dipeptides; Drug Discovery; Fungi; Microbial Sensitivity Tests | 2009 |
Design, synthesis and biological evaluations of novel 7-[3-(1-aminocycloalkyl)pyrrolidin-1-yl]-6-desfluoro-8-methoxyquinolones with potent antibacterial activity against multi-drug resistant Gram-positive bacteria.
Topics: Anti-Bacterial Agents; Drug Design; Drug Resistance, Multiple; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinolones; Structure-Activity Relationship | 2009 |
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Glycopeptides; Gram-Positive Bacteria; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus | 2009 |
Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.
Topics: Antitubercular Agents; Cysteine; Drug Evaluation, Preclinical; Mycobacterium; Mycobacterium smegmatis; Organoselenium Compounds; Selenocysteine; Small Molecule Libraries | 2009 |
Synthesis and antibacterial activity of isothiazolyl oxazolidinones and analogous 3(2H)-isothiazolones.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Oxazolidinones; Thiazoles | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The chemical synthesis and antibiotic activity of a diverse library of 2-aminobenzimidazole small molecules against MRSA and multidrug-resistant A. baumannii.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Benzimidazoles; Drug Resistance, Multiple, Bacterial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Conformation; Small Molecule Libraries; Stereoisomerism; Structure-Activity Relationship | 2010 |
Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates.
Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones; Taiwan | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Design; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Methicillin-Resistant Staphylococcus aureus; Streptococcus pneumoniae | 2010 |
Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR.
Topics: Bacterial Proteins; Drug Resistance, Bacterial; Indoles; Microbial Sensitivity Tests; Mutation; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; Staphylococcus aureus; Structure-Activity Relationship; Substrate Specificity | 2010 |
4-Substituted 4-(1H-1,2,3-triazol-1-yl)piperidine: novel C7 moieties of fluoroquinolones as antibacterial agents.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Microbial Sensitivity Tests; Naphthyridines; Piperidines | 2010 |
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; Carrier Proteins; Child; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Molecular Epidemiology; Norfloxacin; Point Mutation; Portugal; Streptococcal Infections; Streptococcus pyogenes | 2010 |
Design, synthesis, and antibacterial activity of 2,5-dihydropyrrole formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
Topics: Amidohydrolases; Amines; Anti-Bacterial Agents; Drug Design; Pyrroles; Structure-Activity Relationship | 2010 |
First report of the multidrug resistance gene cfr and the phenicol resistance gene fexA in a Bacillus strain from swine feces.
Topics: Animals; Anti-Bacterial Agents; Bacillus; Bacterial Proteins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Feces; Lincosamides; Macrolides; Microbial Sensitivity Tests; Molecular Sequence Data; Streptogramin B; Swine | 2010 |
Inhibition of antibiotic-resistant Staphylococcus aureus by the broad-spectrum dihydrofolate reductase inhibitor RAB1.
Topics: Anti-Bacterial Agents; Enzyme Inhibitors; Inhibitory Concentration 50; Microbial Sensitivity Tests; Protein Structure, Secondary; Protein Structure, Tertiary; Staphylococcus aureus; Tetrahydrofolate Dehydrogenase | 2010 |
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.
Topics: Anti-Bacterial Agents; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests | 2010 |
Subinhibitory concentrations of protein synthesis-inhibiting antibiotics promote increased expression of the agr virulence regulator and production of phenol-soluble modulin cytolysins in community-associated methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cytotoxins; Methicillin-Resistant Staphylococcus aureus; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Trans-Activators; Virulence | 2010 |
Comparative efficacies of human simulated exposures of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a range of vancomycin MICs in a murine pneumonia model.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Disease Models, Animal; Female; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pneumonia; Staphylococcal Infections; Vancomycin | 2010 |
In vitro and in vivo activities of LCB01-0371, a new oxazolidinone.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bacterial Infections; Gram-Positive Bacteria; Linezolid; Male; Mice; Mice, Inbred ICR; Oxazolidinones; Staphylococcus aureus; Vancomycin | 2010 |
The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Phenylalanine; Rhodanine; Stereoisomerism; Structure-Activity Relationship | 2010 |
Design, synthesis and antibacterial activity of 3-methylenepyrrolidine formyl hydroxyamino derivatives as novel peptide deformylase inhibitors.
Topics: Amidohydrolases; Anti-Bacterial Agents; Drug Design; Drug Resistance, Bacterial; Enzyme Inhibitors; Haemophilus influenzae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrrolidines | 2011 |
Exploration of the activity of 7-pyrrolidino-8-methoxyisothiazoloquinolones against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Anti-Bacterial Agents; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Escherichia coli; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrrolidines; Quinolones; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Topoisomerase II Inhibitors | 2011 |
Selenophene-containing inhibitors of type IIA bacterial topoisomerases.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; DNA Topoisomerase IV; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Methicillin-Resistant Staphylococcus aureus; Organoselenium Compounds; Piperidines; Quinolines; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Thiophenes; Topoisomerase II Inhibitors | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
7-Alkyl-N(2)-substituted-3-deazaguanines. Synthesis, DNA polymerase III inhibition and antibacterial activity.
Topics: Animals; Anti-Bacterial Agents; DNA Polymerase III; Enzyme Inhibitors; Escherichia coli; Gram-Positive Bacteria; Guanine; Mice; Microbial Sensitivity Tests; Staphylococcal Infections | 2011 |
Synthesis, antimicrobial activity and possible mechanism of action of 9-bromo-substituted indolizinoquinoline-5,12-dione derivatives.
Topics: Anti-Bacterial Agents; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Models, Molecular; Quinolines; Spectrometry, Mass, Electrospray Ionization | 2011 |
Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Methicillin-Resistant Staphylococcus aureus; Models, Molecular; Molecular Structure; Structure-Activity Relationship | 2012 |
Discovery of nosokophic acid, a predicted intermediate of moenomycins, from nosokomycin-producing Streptomyces sp. K04-0144.
Topics: Anti-Bacterial Agents; Bambermycins; Drug Discovery; Drug Synergism; Hexuronic Acids; Imipenem; Magnetic Resonance Spectroscopy; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Organophosphates; Streptomyces | 2013 |
Synthesis and in vitro activity of 1,2,4-triazole-ciprofloxacin hybrids against drug-susceptible and drug-resistant bacteria.
Topics: Anti-Bacterial Agents; Cells, Cultured; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; HEK293 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2013 |
Synthesis using microwave irradiation and antibacterial evaluation of new N,O-acetals and N,S-acetals derived from 2-amino-1,4-naphthoquinones.
Topics: Acetals; Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Microwaves; Models, Chemical; Molecular Structure; Naphthoquinones; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared | 2013 |
3-Anhydro-6-hydroxy-ophiobolin A, a new sesterterpene inhibiting the growth of methicillin-resistant Staphylococcus aureus and inducing the cell death by apoptosis on K562, from the phytopathogenic fungus Bipolaris oryzae.
Topics: Apoptosis; Cell Death; Drug Screening Assays, Antitumor; Flow Cytometry; Hep G2 Cells; Humans; K562 Cells; Methicillin-Resistant Staphylococcus aureus; Oryza; Sesterterpenes; Structure-Activity Relationship | 2013 |
The synthesis and SAR study of phenylalanine-derived (Z)-5-arylmethylidene rhodanines as anti-methicillin-resistant Staphylococcus aureus (MRSA) compounds.
Topics: Anti-Bacterial Agents; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phenylalanine; Rhodanine; Structure-Activity Relationship; Vancomycin | 2013 |
Inducing secondary metabolite production by the endophytic fungus Fusarium tricinctum through coculture with Bacillus subtilis.
Topics: Aristolochia; Bacillus subtilis; Coculture Techniques; Depsipeptides; Enterococcus faecalis; Fusarium; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Staphylococcus aureus; Streptococcus pneumoniae | 2013 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Proliferation; Circular Dichroism; Drug Resistance, Multiple; Gram-Negative Bacteria; Humans; Liposomes; Microbial Sensitivity Tests; Molecular Structure; Neoplasms; Peptidomimetics; Structure-Activity Relationship; Tumor Cells, Cultured | 2014 |
Antibacterial evaluation of structurally amphipathic, membrane active small cationic peptidomimetics: synthesized by incorporating 3-amino benzoic acid as peptidomimetic element.
Topics: Anti-Bacterial Agents; Benzoic Acid; Cell Line; Cell Membrane; Drug Design; Drug Resistance, Bacterial; Drug Stability; Erythrocytes; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Kinetics; Methicillin-Resistant Staphylococcus aureus; Models, Molecular; Molecular Conformation; Peptidomimetics | 2014 |
Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Carbohydrates; Catalytic Domain; Cell Line; Chemistry Techniques, Synthetic; Click Chemistry; Drug Design; Fungi; Microbial Sensitivity Tests; Models, Molecular; Penicillin-Binding Proteins; Triazoles | 2014 |
Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
Topics: Amidohydrolases; Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enzyme Inhibitors; Microbial Sensitivity Tests; Molecular Structure; Oligopeptides; Structure-Activity Relationship | 2014 |
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives.
Topics: Animals; Anti-Bacterial Agents; Chalcones; Chemistry Techniques, Synthetic; Chlorocebus aethiops; Chromones; DNA Gyrase; DNA Topoisomerase IV; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phloroglucinol; Structure-Activity Relationship; Topoisomerase II Inhibitors; Vero Cells | 2014 |
Bacillusin A, an Antibacterial Macrodiolide from Bacillus amyloliquefaciens AP183.
Topics: Anti-Bacterial Agents; Bacillus; Candida albicans; Drug Resistance, Bacterial; Enterococcus faecium; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Polyenes; Staphylococcus aureus; Vancomycin | 2015 |
Search for factors affecting antibacterial activity and toxicity of 1,2,4-triazole-ciprofloxacin hybrids.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; HEK293 Cells; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 2015 |
Thiol activated prodrugs of sulfur dioxide (SO2) as MRSA inhibitors.
Topics: Anti-Bacterial Agents; Drug Design; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Prodrugs; Staphylococcal Infections; Structure-Activity Relationship; Sulfhydryl Compounds; Sulfur Dioxide | 2015 |
Cytotoxic Homoisoflavones from the Bulbs of Bellevalia eigii.
Topics: HT29 Cells; Humans; Inhibitory Concentration 50; Isoflavones; Jordan; Liliaceae; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium; Mycobacterium smegmatis; Nuclear Magnetic Resonance, Biomolecular; Plant Roots; Structure-Activity Relationship; Vinblastine | 2015 |
Synthesis and evaluation of isatin-β-thiosemicarbazones as novel agents against antibiotic-resistant Gram-positive bacterial species.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Isatin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiosemicarbazones; Vancomycin-Resistant Enterococci | 2015 |
Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Penicillin Resistance; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 2015 |
Biological characterization of the hygrobafilomycin antibiotic JBIR-100 and bioinformatic insights into the hygrolide family of natural products.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Biological Products; Computational Biology; Dose-Response Relationship, Drug; Fungi; Macrolides; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2016 |
Development of a Dual-Acting Antibacterial Agent (TNP-2092) for the Treatment of Persistent Bacterial Infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Rifamycins; Staphylococcus aureus; Structure-Activity Relationship | 2016 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Synthesis and evaluation of in vivo antioxidant, in vitro antibacterial, MRSA and antifungal activity of novel substituted isatin N-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)thiosemicarbazones.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Antioxidants; Cell Line, Tumor; Chemistry Techniques, Synthetic; Drug Evaluation, Preclinical; Isatin; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Rats; Rats, Wistar; Structure-Activity Relationship; Thiosemicarbazones | 2016 |
The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Design; Enzyme Inhibitors; Histidine Kinase; Humans; Microbial Sensitivity Tests; Models, Molecular; Signal Transduction; Thiophenes | 2016 |
Allicin-inspired thiolated fluoroquinolones as antibacterials against ESKAPE pathogens.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Disulfides; Fluoroquinolones; Humans; Methicillin-Resistant Staphylococcus aureus; Sulfhydryl Compounds; Sulfinic Acids | 2016 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Amphiphilic Tobramycin-Lysine Conjugates Sensitize Multidrug Resistant Gram-Negative Bacteria to Rifampicin and Minocycline.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Lysine; Microbial Sensitivity Tests; Minocycline; Models, Biological; Rifampin; Tobramycin | 2017 |
Novel pyridyl nitrofuranyl isoxazolines show antibacterial activity against multiple drug resistant Staphylococcus species.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Oxazoles; Spectrum Analysis; Staphylococcus aureus; Structure-Activity Relationship | 2017 |
Cyclic Cystine-Bridged Peptides from the Marine Sponge Clathria basilana Induce Apoptosis in Tumor Cells and Depolarize the Bacterial Cytoplasmic Membrane.
Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Enterococcus faecium; Indonesia; Marine Biology; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Porifera; Staphylococcus aureus | 2017 |
Hetero-Diels-Alder reactions of novel 3-triazolyl-nitrosoalkenes as an approach to functionalized 1,2,3-triazoles with antibacterial profile.
Topics: Alkenes; Anti-Bacterial Agents; Biofilms; Cycloaddition Reaction; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Nitroso Compounds; Staphylococcus; Structure-Activity Relationship; Triazoles | 2018 |
Disulfiram-based disulfides as narrow-spectrum antibacterial agents.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Disulfiram; Gram-Negative Bacteria; Gram-Positive Bacteria; Half-Life; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Structure; Rats; Vancomycin | 2018 |
In vitro activity of salicylamide derivatives against vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Vancomycin; Vancomycin-Resistant Enterococci | 2018 |
Synthesis and anti-staphylococcal activity of novel bacterial topoisomerase inhibitors with a 5-amino-1,3-dioxane linker moiety.
Topics: Anti-Bacterial Agents; Crystallography, X-Ray; Dioxanes; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Potassium Channel Blockers; Quinolines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2018 |
N-(1,3,4-oxadiazol-2-yl)benzamide analogs, bacteriostatic agents against methicillin- and vancomycin-resistant bacteria.
Topics: Animals; Anti-Bacterial Agents; Benzamides; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacterial Infections; Methicillin; Mice; Microbial Sensitivity Tests; Molecular Structure; Skin Diseases, Bacterial; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin; Wound Infection | 2018 |
Synthesis and antimicrobial evaluation of amino sugar-based naphthoquinones and isoquinoline-5,8-diones and their halogenated compounds.
Topics: Amino Sugars; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Halogenation; Hemolysis; Humans; Isoquinolines; Naphthoquinones | 2018 |
Synthesis and antimicrobial studies of hydrazone derivatives of 4-[3-(2,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid and 4-[3-(3,4-difluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic acid.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacillus subtilis; Benzoates; Dose-Response Relationship, Drug; Hydrazones; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship | 2018 |
1-(2-Hydroxybenzoyl)-thiosemicarbazides are promising antimicrobial agents targeting d-alanine-d-alanine ligase in bacterio.
Topics: Anti-Bacterial Agents; Cell Survival; Dose-Response Relationship, Drug; Enterococcus faecalis; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Peptide Synthases; Semicarbazides; Staphylococcus aureus; Structure-Activity Relationship; THP-1 Cells | 2018 |
Novel indole-thiazolidinone conjugates: Design, synthesis and whole-cell phenotypic evaluation as a novel class of antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cell Line; Dose-Response Relationship, Drug; Drug Design; Fungi; Humans; Indoles; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Phenotype; RAW 264.7 Cells; Structure-Activity Relationship; Thiazolidines | 2018 |
Bile Acid Oligomers and Their Combination with Antibiotics To Combat Bacterial Infections.
Topics: Anti-Bacterial Agents; Bile Acids and Salts; Drug Interactions; Drug Resistance, Bacterial; Escherichia coli; HEK293 Cells; Humans; Staphylococcus aureus | 2018 |
Synthesis, antituberculosis studies and biological evaluation of new quinoline derivatives carrying 1,2,4-oxadiazole moiety.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Quinolines; Structure-Activity Relationship | 2019 |
Efficient click chemistry towards novel 1H-1,2,3-triazole-tethered 4H-chromene-d-glucose conjugates: Design, synthesis and evaluation of in vitro antibacterial, MRSA and antifungal activities.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Benzopyrans; Click Chemistry; Drug Design; Fungi; Glucose; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; RAW 264.7 Cells; Triazoles | 2019 |
Antibacterial activity of indolyl-quinolinium derivatives and study their mode of action.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests; Molecular Structure; Quinolinium Compounds; Structure-Activity Relationship | 2019 |
Design, synthesis and biological evaluation of antimicrobial diarylimine and -amine compounds targeting the interaction between the bacterial NusB and NusE proteins.
Topics: Aniline Compounds; Anti-Bacterial Agents; Bacterial Proteins; Benzylamines; Caco-2 Cells; Drug Design; Erythrocytes; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Hemolysis; Humans; Keratinocytes; Microbial Sensitivity Tests; Molecular Structure; Protein Binding; Schiff Bases; Structure-Activity Relationship; Transcription Factors | 2019 |
Discovery of 1,3,4-oxadiazol-2-one-containing benzamide derivatives targeting FtsZ as highly potent agents of killing a variety of MDR bacteria strains.
Topics: Bacterial Proteins; Benzamides; Cytoskeletal Proteins; Methicillin-Resistant Staphylococcus aureus | 2019 |
Chemoproteomics of an Indole-Based Quinone Epoxide Identifies Druggable Vulnerabilities in Vancomycin-Resistant
Topics: Anti-Bacterial Agents; Benzoquinones; Drug Discovery; Epoxy Compounds; Humans; Indoles; Models, Molecular; Proteomics; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2019 |
Virtual Screening Approach and Investigation of Structure-Activity Relationships To Discover Novel Bacterial Topoisomerase Inhibitors Targeting Gram-Positive and Gram-Negative Pathogens.
Topics: Amino Acid Sequence; Bacterial Infections; DNA Gyrase; DNA Topoisomerase IV; Escherichia coli; Microbial Sensitivity Tests; Models, Chemical; Molecular Structure; Sequence Homology, Amino Acid; Staphylococcus aureus; Structure-Activity Relationship; Topoisomerase Inhibitors | 2019 |
Design of Trp-Rich Dodecapeptides with Broad-Spectrum Antimicrobial Potency and Membrane-Disruptive Mechanism.
Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Bacterial Outer Membrane; Drug Design; Escherichia coli; Humans; Microbial Sensitivity Tests; Oligopeptides; Peptide Fragments; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus; Tryptophan | 2019 |
Anthraquinone-Based Specialized Metabolites from Rhizomes of
Topics: Anthraquinones; Anti-Bacterial Agents; Antifungal Agents; Asphodelaceae; Microbial Sensitivity Tests; Molecular Structure; Rhizome; Spectrum Analysis | 2019 |
The synthesis and in vitro biological evaluation of novel fluorinated tetrahydrobenzo[j]phenanthridine-7,12-diones against Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Benzophenanthridines; Cell Line; Dose-Response Relationship, Drug; Humans; Hydrocarbons, Fluorinated; Macrophages; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship | 2019 |
An overview of recent progress in siderophore-antibiotic conjugates.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Siderophores; Structure-Activity Relationship | 2019 |
4-Substituted picolinohydrazonamides as a new class of potential antitubercular agents.
Topics: Animals; Antitubercular Agents; Bacteria; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Pyridines; Thiosemicarbazones; Yeasts | 2020 |
Machine Learning in Mass Spectrometry: A MALDI-TOF MS Approach to Phenotypic Antibacterial Screening.
Topics: Anti-Bacterial Agents; Escherichia coli; Machine Learning; Microbial Sensitivity Tests; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus | 2020 |
Design, synthesis and biological evaluation of novel hybrids of N-aryl pyrrothine-base α-pyrone as bacterial RNA polymerase inhibitors.
Topics: Anti-Bacterial Agents; Binding Sites; Candida albicans; Cell Survival; DNA-Directed RNA Polymerases; Drug Design; Enzyme Inhibitors; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Pyrones; Structure-Activity Relationship | 2020 |
Novel bacterial topoisomerase inhibitors derived from isomannide.
Topics: Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Dose-Response Relationship, Drug; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Topoisomerase Inhibitors | 2020 |
Pharmacomodulations of the benzoyl-thiosemicarbazide scaffold reveal antimicrobial agents targeting d-alanyl-d-alanine ligase in bacterio.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Escherichia; Microbial Sensitivity Tests; Molecular Structure; Peptide Synthases; Staphylococcus aureus; Structure-Activity Relationship | 2020 |
Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Structure; Staphylococcal Infections; Structure-Activity Relationship; Thiazoles | 2020 |
Lead optimization of 8-(methylamino)-2-oxo-1,2-dihydroquinolines as bacterial type II topoisomerase inhibitors.
Topics: Anti-Bacterial Agents; Cell Survival; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Hep G2 Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Quinolines; Streptococcus pneumoniae; Structure-Activity Relationship; Topoisomerase II Inhibitors; Transcriptional Regulator ERG; Vancomycin-Resistant Enterococci | 2020 |
Synthesis of Natural and Unnatural Quinolones Inhibiting the Growth and Motility of Bacteria.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Bacteria; Cyclization; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Quinolones | 2020 |
Synthesis and biological screening of thiosemicarbazones of substituted 3-acetylcoumarins having d-glucose moiety.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteria; Bacterial Infections; Coumarins; Fungi; Glucose; Humans; Microbial Sensitivity Tests; Mycoses; Structure-Activity Relationship; Thiosemicarbazones | 2020 |
Ultra-short lipopeptides against gram-positive bacteria while alleviating antimicrobial resistance.
Topics: Animals; Anti-Bacterial Agents; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Gram-Positive Bacteria; Lipopeptides; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2021 |
Discovery of novel N
Topics: A549 Cells; Animals; Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cytidine; Drug Discovery; Fungi; Humans; Microbial Sensitivity Tests | 2021 |
4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents.
Topics: Aniline Compounds; Anti-Bacterial Agents; Biofilms; Cell Line; Cell Survival; Drug Resistance, Bacterial; Enterococcus faecalis; Gram-Positive Bacteria; Humans; Liver; Microbial Sensitivity Tests; Pyrazoles; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
A Modular Synthetic Route Involving
Topics: Aniline Compounds; Animals; Anti-Bacterial Agents; Biofilms; Cell Line; Cell Survival; Disease Models, Animal; Drug Design; Female; Halogenation; Humans; Iron; Iron Deficiencies; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Phenazines; Staphylococcal Infections; Structure-Activity Relationship; Wound Healing | 2021 |
Design, synthesis and evaluation of novel 9-arylalkyl-10-methylacridinium derivatives as highly potent FtsZ-targeting antibacterial agents.
Topics: Acridines; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
Antimicrobial, modulatory, and antibiofilm activity of tt-farnesol on bacterial and fungal strains of importance to human health.
Topics: Anti-Bacterial Agents; Biofilms; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Molecular Docking Simulation; Molecular Structure; Structure-Activity Relationship | 2021 |
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Pneumonia, Bacterial; Pore Forming Cytotoxic Proteins; Structure-Activity Relationship; Wasp Venoms | 2021 |
Synthetic cajaninstilbene acid derivatives eradicate methicillin-resistant Staphylococcus aureus persisters and biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Survival; Cell Wall; Disease Models, Animal; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; RAW 264.7 Cells; Salicylates; Skin Diseases; Staphylococcal Infections; Staphylococcus aureus; Stilbenes; Structure-Activity Relationship | 2021 |
Modification of 5-methylphenanthridium from benzothiazoles to indoles as potent FtsZ inhibitors: Broadening the antibacterial spectrum toward vancomycin-resistant enterococci.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzothiazoles; Cytoskeletal Proteins; Humans; Indoles; Molecular Structure; Phenanthridines; Structure-Activity Relationship; Vancomycin-Resistant Enterococci | 2021 |
Optimization of TopoIV Potency, ADMET Properties, and hERG Inhibition of 5-Amino-1,3-dioxane-Linked Novel Bacterial Topoisomerase Inhibitors: Identification of a Lead with
Topics: Anti-Bacterial Agents; Dioxanes; DNA Gyrase; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ether-A-Go-Go Potassium Channels; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2021 |
Design, synthesis, and antibacterial activity of
Topics: | 2021 |
Multifunctional Antibiotic-Host Defense Peptide Conjugate Kills Bacteria, Eradicates Biofilms, and Modulates the Innate Immune Response.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteria; Biofilms; Humans; Immunity, Innate; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus epidermidis | 2021 |
SF
Topics: | 2021 |
An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a.
Topics: Allosteric Regulation; Allosteric Site; Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Drug Design; Drug Resistance, Multiple; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Docking Simulation; Naphthalimides; Oxidative Stress; Oximes; Penicillin-Binding Proteins; Structure-Activity Relationship | 2022 |
Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cell Survival; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Molecular Structure; Multidrug Resistance-Associated Proteins; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship; THP-1 Cells | 2022 |
Small Amphiphilic Peptides: Activity Against a Broad Range of Drug-Resistant Bacteria and Structural Insight into Membranolytic Properties.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacteria; Cell Membrane; Cell Survival; Drug Design; Gram-Negative Bacteria; Gram-Positive Bacteria; HEK293 Cells; Hemolysis; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Dynamics Simulation; Peptides | 2022 |
Metallo-β-lactamases inhibitor fisetin attenuates meropenem resistance in NDM-1-producing Escherichia coli.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Escherichia coli; Flavonols; Meropenem; Microbial Sensitivity Tests | 2022 |
Amphiphilic cyclic peptide [W
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Meropenem; Microbial Sensitivity Tests; Peptides, Cyclic; Pseudomonas aeruginosa | 2022 |
Design, synthesis, and biological evaluations of substituted pyrazoles as pyrrolomycin analogues against staphylococcal biofilm.
Topics: Anti-Bacterial Agents; Biofilms; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrazoles; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus | 2022 |
Design and synthesis of quinolinium-based derivatives targeting FtsZ for antibacterial evaluation and mechanistic study.
Topics: Amines; Anti-Bacterial Agents; Bacterial Proteins; Cytoskeletal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Staphylococcus aureus; Staphylococcus epidermidis; Structure-Activity Relationship | 2022 |
1,3-Dioxane-Linked Novel Bacterial Topoisomerase Inhibitors: Expanding Structural Diversity and the Antibacterial Spectrum.
Topics: | 2022 |
Design, synthesis, and biological evaluation of membrane-active honokiol derivatives as potent antibacterial agents.
Topics: Allyl Compounds; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Biphenyl Compounds; Lignans; Mice; Microbial Sensitivity Tests; Phenols | 2022 |
An unanticipated discovery of novel naphthalimidopropanediols as potential broad-spectrum antibacterial members.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Mammals; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 2022 |
Targeting Vancomycin-Resistant
Topics: Anti-Bacterial Agents; Cholic Acid; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Operon; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2022 |
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Quinolones; Streptococcus pneumoniae; Vancomycin; Virginiamycin | 1992 |
Pharmacokinetics of ciprofloxacin and vancomycin in patients with acute renal failure treated by continuous haemodialysis.
Topics: Acute Kidney Injury; Adult; Aged; Ciprofloxacin; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis; Vancomycin | 1992 |
CI-960, a new fluoroquinolone, for therapy of experimental ciprofloxacin-susceptible and -resistant Staphylococcus aureus endocarditis.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Endocarditis, Bacterial; Fluoroquinolones; Kidney; Male; Methicillin Resistance; Microbial Sensitivity Tests; Quinolones; Rabbits; Spleen; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.
Topics: Animals; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Eye Infections, Bacterial; Keratitis; Microbial Sensitivity Tests; Ophthalmic Solutions; Rabbits; Random Allocation; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
The in-vitro activity of RP 59500 against gram-positive cocci.
Topics: Amoxicillin; Ciprofloxacin; Erythromycin; Gram-Positive Cocci; In Vitro Techniques; Josamycin; Methicillin Resistance; Microbial Sensitivity Tests; Vancomycin; Virginiamycin | 1992 |
Comparative in-vitro activity of RP 59500.
Topics: Bacteria; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Oxacillin; Vancomycin; Virginiamycin | 1992 |
Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; beta-Lactamases; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Female; Gram-Positive Bacterial Infections; Hospital Bed Capacity; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Prospective Studies; Risk Factors; Teicoplanin; United States; Vancomycin; Virulence | 1992 |
[Development of resistance in bacteria interacting with subinhibitory antibiotic concentrations].
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas; Serial Passage; Staphylococcus aureus; Vancomycin | 1992 |
Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin.
Topics: Animals; Cefazolin; Ciprofloxacin; Corneal Ulcer; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Methicillin Resistance; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
Modification of central venous catheter flush solution improves in vitro antimicrobial activity.
Topics: Catheterization, Central Venous; Ciprofloxacin; Equipment Contamination; Heparin; Humans; Microbial Sensitivity Tests; Solutions; Vancomycin | 1992 |
In vitro and in vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethylmethacrylate beads.
Topics: Animals; Anti-Bacterial Agents; Bone and Bones; Cefazolin; Ciprofloxacin; Clindamycin; Diffusion; Dogs; Granulation Tissue; Methylmethacrylates; Ticarcillin; Tobramycin; Vancomycin | 1992 |
An assessment of the efficacy of antimicrobial prophylaxis in bone marrow autografts.
Topics: Adolescent; Adult; Amphotericin B; Bacteremia; Bacterial Infections; Bone Marrow Transplantation; Ciprofloxacin; Drug Therapy, Combination; Erythromycin; Female; Humans; Male; Middle Aged; Mycoses; Neutropenia; Transplantation, Autologous; Vancomycin | 1991 |
Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Glycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1991 |
Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Diffusion Chambers, Culture; Disease Models, Animal; Drug Resistance, Microbial; Fleroxacin; Foreign Bodies; Gentamicins; Kinetics; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1991 |
Effects of carbon dioxide and sub-lethal levels of antibiotics on adherence of coagulase-negative staphylococci to polystyrene and silicone rubber.
Topics: Anti-Bacterial Agents; Bacterial Adhesion; Carbon Dioxide; Cefuroxime; Ciprofloxacin; Humans; Membrane Proteins; Polystyrenes; Reproducibility of Results; Silicone Elastomers; Staphylococcus; Vancomycin | 1991 |
Vancomycin-resistant Corynebacterium species causing prosthetic valve endocarditis successfully treated with imipenem and ciprofloxacin.
Topics: Adult; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Heart Valve Prosthesis; Humans; Imipenem; Mitral Valve; Species Specificity; Vancomycin | 1991 |
Successful single-dose prophylaxis of Staphylococcus aureus foreign body infections in guinea pigs by fleroxacin.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Fleroxacin; Foreign Bodies; Guinea Pigs; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1990 |
Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Fleroxacin; Foreign-Body Reaction; Male; Methicillin Resistance; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1990 |
Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis.
Topics: Animals; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Male; Methicillin; Osteomyelitis; Pefloxacin; Penicillin Resistance; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Vancomycin | 1990 |
Continuous ambulatory peritoneal dialysis (CAPD) peritonitis: the effect of antibiotic on the adherence of coagulase-negative staphylococci to silicone rubber catheter material.
Topics: Bacterial Adhesion; Catheters, Indwelling; Cefuroxime; Ciprofloxacin; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Silicone Elastomers; Staphylococcus epidermidis; Vancomycin | 1989 |
Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against staphylococci and streptococci.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Glycopeptides; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus; Streptococcus; Teicoplanin; Vancomycin | 1989 |
Comparison of in vitro activity of daptomycin, vancomycin and fluoroquinolones in broth and serum against Staphylococcus epidermidis as determined by time-kill kinetics.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Daptomycin; Fluoroquinolones; Kinetics; Microbial Sensitivity Tests; Peptides; Staphylococcus epidermidis; Vancomycin | 1989 |
Activity of LY146032 compared with that of methicillin, cefazolin, cefamandole, cefuroxime, ciprofloxacin, and vancomycin against staphylococci as determined by kill-kinetic studies.
Topics: Anti-Bacterial Agents; Cefamandole; Cefazolin; Cefuroxime; Ciprofloxacin; Culture Media; Daptomycin; Kinetics; Methicillin; Microbial Sensitivity Tests; Peptides; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin | 1987 |
Bactericidal activity of deptomycin (LY146032) compared with those of ciprofloxacin, vancomycin, and ampicillin against enterococci as determined by kill-kinetic studies.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Peptides; Vancomycin | 1987 |
Comparative efficacy of pefloxacin and six other antimicrobial agents on Staphylococcus aureus experimental abscesses.
Topics: Abscess; Administration, Oral; Animals; Anti-Bacterial Agents; Cephalothin; Ciprofloxacin; Injections, Subcutaneous; Methicillin; Mice; Norfloxacin; Pefloxacin; Penicillin Resistance; Peptides; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Thigh; Vancomycin; Virginiamycin | 1986 |
In vitro antistaphylococcal activity of teicoplanin and ciprofloxacin in peritoneal dialysis effluent.
Topics: Anti-Bacterial Agents; Ascitic Fluid; Cefazolin; Ciprofloxacin; Glycopeptides; Humans; Oxacillin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Staphylococcus; Staphylococcus epidermidis; Teicoplanin; Vancomycin | 1986 |
The effect of anaerobiosis on antistaphylococcal antibiotics.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anaerobiosis; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Clavulanic Acids; Clindamycin; Coagulase; Drug Therapy, Combination; Glycopeptides; Microbial Sensitivity Tests; Staphylococcus; Teicoplanin; Ticarcillin; Tobramycin; Vancomycin | 1988 |
Comparative in-vitro activities of teicoplanin, vancomycin, coumermycin and ciprofloxacin, alone and in combination with rifampicin or LM 427, against Staphylococcus aureus.
Topics: Aminocoumarins; Anti-Bacterial Agents; Cell Wall; Ciprofloxacin; Coumarins; DNA-Directed RNA Polymerases; Drug Interactions; Glycopeptides; Humans; Rifabutin; Rifampin; Rifamycins; Staphylococcus aureus; Teicoplanin; Topoisomerase II Inhibitors; Vancomycin | 1987 |
Activity of ciprofloxacin against multiply resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, and group JK corynebacteria.
Topics: Actinomycetales; Cefotaxime; Ciprofloxacin; Gentamicins; Humans; Methicillin; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillin Resistance; Pseudomonas aeruginosa; Staphylococcus epidermidis; Ticarcillin; Vancomycin | 1986 |
Identification of Streptococcus faecalis and Streptococcus faecium and susceptibility studies with newly developed antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Enterococcus faecalis; Erythromycin; Fluoroquinolones; Humans; Imipenem; Microbial Sensitivity Tests; Quinolines; Streptococcus; Thienamycins; Vancomycin | 1987 |
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin | 1988 |
[Comparative bactericidal kinetics of ciprofloxacin, ofloxacin and pefloxacin alone and in combination against strains of group D Streptococcus].
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Penicillin G; Vancomycin | 1988 |
[Post-antibiotic effect of ciprofloxacin alone and in combination on Streptococcus faecalis].
Topics: Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Fosfomycin; Microbial Sensitivity Tests; Netilmicin; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Vancomycin | 1988 |
[Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Enoxacin; Female; Humans; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Peptides, Cyclic; Pipemidic Acid; Rifampin; Tetracycline; Tetracycline Resistance; Urinary Tract Infections; Vancomycin; Virginiamycin | 1988 |
Comparative killing activity and postantibiotic effect of streptomycin combined with ampicillin, ciprofloxacin, imipenem, piperacillin or vancomycin against strains of Streptococcus faecalis and Streptococcus faecium.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Enterococcus faecalis; Imipenem; Piperacillin; Streptococcus; Streptomycin; Thienamycins; Vancomycin | 1988 |
Interaction of ciprofloxacin with ampicillin and vancomycin for Streptococcus faecalis.
Topics: Ampicillin; Ciprofloxacin; Drug Interactions; Drug Synergism; Enterococcus faecalis; Microbial Sensitivity Tests; Vancomycin | 1988 |
The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fusidic Acid; Gentamicins; Glycopeptides; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Quinolines; Rifampin; Staphylococcus aureus; Staphylococcus Phages; Teicoplanin; Vancomycin | 1985 |
Susceptibility of Clostridium difficile strains to new antibiotics: quinolones, efrotomycin, teicoplanin and imipenem.
Topics: Ciprofloxacin; Clostridium; Glycopeptides; Imipenem; Microbial Sensitivity Tests; Pyridones; Quinolines; Teicoplanin; Thienamycins; Vancomycin | 1985 |
Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus.
Topics: Animals; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Imipenem; Methicillin; Nafcillin; Penicillin Resistance; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Thienamycins; Vancomycin | 1988 |
In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Chemical Phenomena; Chemistry; Ciprofloxacin; Erythromycin; Gram-Positive Bacteria; Oxazoles; Oxazolidinones; Vancomycin | 1988 |
A clinical, microbiological and pharmacokinetic study of ciprofloxacin plus vancomycin as initial therapy of febrile episodes in neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; Leukemia; Middle Aged; Neutropenia; Vancomycin | 1988 |
The emergence of resistance to ciprofloxacin during treatment of experimental Staphylococcus aureus endocarditis.
Topics: Animals; Blood Bactericidal Activity; Ciprofloxacin; Drug Resistance, Microbial; Endocarditis, Bacterial; Male; Microbial Sensitivity Tests; Rabbits; Staphylococcus aureus; Vancomycin | 1987 |
In vitro assessment of CI-934--a new quinolone derivative.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Ciprofloxacin; Enoxacin; Erythromycin; Fluoroquinolones; Gentamicins; Kinetics; Naphthyridines; Quinolines; Streptococcus; Streptococcus pneumoniae; Vancomycin | 1986 |
In vitro activity of CI-934 compared with ciprofloxacin, enoxacin, norfloxacin, and vancomycin.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Enoxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Norfloxacin; Quinolines; Vancomycin | 1987 |
In vitro activity of ciprofloxacin against gram-positive cocci.
Topics: Ciprofloxacin; Drug Evaluation, Preclinical; Enterobacteriaceae; Fusidic Acid; Gram-Positive Bacteria; Microbial Sensitivity Tests; Staphylococcus; Streptococcus; Vancomycin | 1987 |
Treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis with ciprofloxacin or vancomycin alone or in combination with rifampin.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Osteomyelitis; Rats; Rats, Inbred Strains; Rifampin; Staphylococcal Infections; Vancomycin | 1987 |
Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Gentamicins; Kinetics; Methicillin; Microbial Sensitivity Tests; Norfloxacin; Penicillin Resistance; Staphylococcus aureus; Vancomycin | 1986 |
Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis.
Topics: Animals; Ciprofloxacin; Drug Evaluation, Preclinical; Endocarditis, Bacterial; Kinetics; Methicillin; Penicillin Resistance; Rabbits; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1987 |
Altered pharmacokinetic disposition of ciprofloxacin and vancomycin after single and multiple doses in rabbits.
Topics: Animals; Ciprofloxacin; Injections, Intravenous; Kinetics; Male; Rabbits; Vancomycin | 1987 |
Interaction between ciprofloxacin and vancomycin against staphylococci.
Topics: Ciprofloxacin; Drug Combinations; Drug Interactions; Microbial Sensitivity Tests; Staphylococcus; Vancomycin | 1987 |
Bactericidal activity and killing rate of serum in volunteers receiving ciprofloxacin alone or in combination with vancomycin.
Topics: Ciprofloxacin; Drug Combinations; Drug Interactions; Gram-Positive Bacteria; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Random Allocation; Vancomycin | 1986 |
Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fluoroquinolones; Foreign Bodies; Guinea Pigs; Methicillin Resistance; Microbial Sensitivity Tests; Quinolones; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
Comparison of simple methods of methicillin-resistance detection and evaluation of some properties of methicillin-resistant Staphylococcus aureus strains.
Topics: Ciprofloxacin; Cross Infection; Evaluation Studies as Topic; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Teicoplanin; Vancomycin | 1993 |
Different patterns of bacterial DNA synthesis during postantibiotic effect.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Dicloxacillin; DNA, Bacterial; Escherichia coli; Gentamicins; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rifampin; Staphylococcus aureus; Tobramycin; Vancomycin | 1995 |
Fluconazole is removed by continuous venovenous hemofiltration in a liver transplant patient.
Topics: Anuria; Candidiasis; Ciprofloxacin; Cyclosporine; Fluconazole; Hemofiltration; Humans; Liver Transplantation; Male; Middle Aged; Vancomycin | 1995 |
In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
Topics: Ciprofloxacin; Drug Interactions; Drug Therapy, Combination; Fosfomycin; Fusidic Acid; Gentamicins; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcus aureus; Vancomycin | 1994 |
In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Depsipeptides; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Novobiocin; Peptides, Cyclic; Quinolones; Teicoplanin; Vancomycin; Virginiamycin | 1995 |
Effects of ciprofloxacin and vancomycin on physicochemical surface properties of Staphylococcus epidermidis, Escherichia coli, Lactobacillus casei and Lactobacillus acidophilus.
Topics: Alkanes; Bacterial Adhesion; Cell Membrane; Ciprofloxacin; Electrophoresis, Polyacrylamide Gel; Escherichia coli; Hydrogen-Ion Concentration; Isoelectric Point; Lacticaseibacillus casei; Lactobacillus acidophilus; Spectrometry, X-Ray Emission; Staphylococcus epidermidis; Vancomycin | 1995 |
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.
Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Kinetics; Microbial Sensitivity Tests; Penicillin G; Quinolones; Streptococcus pneumoniae; Time Factors; Vancomycin; Virginiamycin | 1994 |
[Absence of chemical interaction between short catheters (ETFE) and three major antibiotics. Study model].
Topics: Amoxicillin; Anti-Bacterial Agents; Catheterization; Ciprofloxacin; Clavulanic Acids; Drug Combinations; In Vitro Techniques; Vancomycin | 1994 |
Efficacy of ciprofloxacin in treatment and prophylaxis of experimental Staphylococcus aureus endocarditis caused by a cloxacillin-tolerant strain and its non-tolerant variant.
Topics: Animals; Ciprofloxacin; Cloxacillin; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Rats; Rats, Wistar; Serum Bactericidal Test; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1994 |
Cerebrospinal fluid shunt infection due to Corynebacterium xerosis.
Topics: Ciprofloxacin; Corynebacterium Infections; Drug Resistance, Microbial; Equipment Contamination; Humans; Infant, Newborn; Male; Species Specificity; Vancomycin; Ventriculoperitoneal Shunt | 1994 |
Comparative prophylactic efficacies of ciprofloxacin, ofloxacin, cefazolin, and vancomycin in experimental model of staphylococcal wound infection.
Topics: Animals; Cefazolin; Ciprofloxacin; Drug Resistance, Microbial; Female; Guinea Pigs; Male; Ofloxacin; Staphylococcal Infections; Vancomycin; Wound Infection | 1994 |
Bactericidal activities of peptide antibiotics against multidrug-resistant Enterococcus faecium.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Daptomycin; Depsipeptides; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Peptides, Cyclic; Vancomycin | 1994 |
Comparison of topical antibiotics for treating Mycobacterium fortuitum keratitis in an animal model.
Topics: Administration, Topical; Amikacin; Animals; Ciprofloxacin; Clarithromycin; Colony Count, Microbial; Corneal Stroma; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Keratitis; Male; Mycobacterium Infections, Nontuberculous; Ophthalmic Solutions; Rabbits; Vancomycin | 1993 |
Antibiotic treatment of experimental endocarditis due to vancomycin- and ampicillin-resistant Enterococcus faecium.
Topics: Ampicillin Resistance; Animals; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Male; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Rifampin; Vancomycin | 1993 |
Increased susceptibility of Pseudomonas aeruginosa to ciprofloxacin in the presence of vancomycin.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Vancomycin | 1993 |
Endocarditis after ciprofloxacin therapy for enterococcal pyelonephritis with bacteremia.
Topics: Aged; Bacteremia; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pyelonephritis; Vancomycin | 1993 |
In-vitro synergy and mechanism of interaction between vancomycin and ciprofloxacin against enterococcal isolates.
Topics: Bacterial Outer Membrane Proteins; Cell Membrane; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Electrophoresis, Polyacrylamide Gel; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Molecular Weight; Vancomycin | 1993 |
Successful treatment of haemodialysis catheter-related sepsis without catheter removal.
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Ciprofloxacin; Female; Humans; Jugular Veins; Male; Middle Aged; Prospective Studies; Pseudomonas Infections; Renal Dialysis; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1993 |
Prevention of recurrent central venous catheter infections with a novel flush solution in a patient on long-term hemodialysis.
Topics: Bacteremia; Catheterization, Central Venous; Child, Preschool; Ciprofloxacin; Drug Therapy, Combination; Heparin; Humans; Kidney Failure, Chronic; Longitudinal Studies; Male; Recurrence; Renal Dialysis; Vancomycin | 1993 |
Spontaneous ulcerative keratitis in immunocompromised patients.
Topics: Acquired Immunodeficiency Syndrome; Administration, Topical; Adult; Amikacin; Amphotericin B; Candida albicans; Cefazolin; Ciprofloxacin; Corneal Ulcer; Female; Gentamicins; HIV Seropositivity; Humans; Miconazole; Pseudomonas aeruginosa; Staphylococcus aureus; Substance Abuse, Intravenous; Vancomycin; Visual Acuity | 1993 |
Infectious scleritis after a diabetic foot ulcer.
Topics: Administration, Oral; Administration, Topical; Ciprofloxacin; Diabetes Mellitus; Drug Therapy, Combination; Erythromycin; Eye Infections, Bacterial; Foot Ulcer; Humans; Male; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Scleritis; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 1993 |
Single-dose intraperitoneal vancomycin and oral ciprofloxacin for the treatment of peritonitis in CAPD patients: preliminary report.
Topics: Administration, Oral; Ciprofloxacin; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 1993 |
Trends in gram-positive bloodstream organism resistance: a seven-year audit of five glycopeptides and other drugs at a large university hospital.
Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Hospitals, University; Humans; Lactams; Microbial Sensitivity Tests; Ristocetin; Staphylococcus; Time Factors; Vancomycin | 1993 |
Epileptogenic effect of antibiotic drugs.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Ciprofloxacin; Clindamycin; Electroencephalography; Epilepsy; Erythromycin; Hippocampus; Humans; In Vitro Techniques; Penicillins; Rats; Rats, Wistar; Vancomycin | 1993 |
Susceptibility of resistant Enterococcus faecium to unusual antibiotics.
Topics: Ampicillin; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Tetracycline; Vancomycin | 1993 |
[Detection of antibiotic resistance in Enterococcus sp. Comparison of GPS-TA (BioMérieux-Vitek), Uniscept MIC-3 (bioMérieux-Vitek) and conventional methods].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Microbial Sensitivity Tests; Penicillins; Vancomycin | 1995 |
Comparison of the in vitro activity of levofloxacin and other antimicrobial agents against vancomycin-susceptible and vancomycin-resistant Enterococcus species.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Vancomycin | 1995 |
The antimicrobial susceptibility of Streptococcus pyogenes isolates from the Philadelphia area.
Topics: Anti-Bacterial Agents; Cephalothin; Ciprofloxacin; Clindamycin; Erythromycin; Humans; Microbial Sensitivity Tests; Penicillins; Philadelphia; Rifampin; Streptococcal Infections; Streptococcus pyogenes; Vancomycin | 1995 |
Antibiotic-resistant endocarditis in a hemodialysis patient.
Topics: Ampicillin; Bacteremia; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Teicoplanin; Vancomycin | 1996 |
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Ciprofloxacin; Cyclophosphamide; Estrogens; Female; Genetic Diseases, Inborn; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Incidence; Life Tables; Liver Diseases; Liver Function Tests; Male; Methotrexate; Middle Aged; Multiple Organ Failure; Multivariate Analysis; Neoplasms; Progestins; Retrospective Studies; Risk Factors; Transplantation Conditioning; Vancomycin | 1996 |
Experimental posttraumatic Bacillus cereus endophthalmitis in a swine model. Efficacy of intravitreal ciprofloxacin, vancomycin, and imipenem.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacillaceae Infections; Bacillus cereus; Ciprofloxacin; Disease Models, Animal; Endophthalmitis; Eye Diseases; Eye Infections, Bacterial; Eye Injuries, Penetrating; Imipenem; Pilot Projects; Random Allocation; Retinitis; Swine; Thienamycins; Vancomycin; Vitreous Body | 1996 |
The Etest for antimicrobial susceptibility testing of Bartonella henselae.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bartonella henselae; Cats; Ciprofloxacin; Doxycycline; Erythromycin; Humans; Microbial Sensitivity Tests; Rifampin; Vancomycin | 1996 |
Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Diagnostic Errors; Drug Therapy, Combination; Humans; Mycobacterium Infections; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin | 1997 |
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin | 1996 |
Dosage adjustment of antiinfective therapy in patients with renal impairment.
Topics: Aminoglycosides; Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Creatinine; Dose-Response Relationship, Drug; Drug Monitoring; Female; Half-Life; Humans; Kidney Diseases; Male; Middle Aged; Renal Dialysis; Retrospective Studies; Vancomycin | 1997 |
Antibiotic prophylaxis in gastrointestinal endoscopy: a report by a Working Party for the British Society of Gastroenterology Endoscopy Committee.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Ciprofloxacin; Drug Hypersensitivity; Endocarditis, Bacterial; Endoscopy, Gastrointestinal; Gentamicins; Humans; Immunocompromised Host; Metronidazole; Neutropenia; Pancreatic Pseudocyst; Penicillins; Risk Factors; Teicoplanin; Vancomycin | 1997 |
Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit.
Topics: Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus; Humans; Imipenem; Intensive Care Units; Outpatients; Pseudomonas aeruginosa; Vancomycin | 1997 |
[Optimal antibacterial chemotherapy for infectious diseases associated with hematological malignancies].
Topics: Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Imipenem; Leukemia; Lymphoma; Male; Middle Aged; Vancomycin | 1997 |
In vitro susceptibilities of clinical isolates of vancomycin-resistant enterococci.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Microbial Sensitivity Tests; Penicillins; Vancomycin; Virginiamycin | 1997 |
In-vitro activity of trovafloxacin against sensitive and resistant aerobic bacteria using the standard microdilution broth method and Etest.
Topics: Ampicillin; Anti-Infective Agents; Bacteria, Aerobic; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Sulbactam; Vancomycin | 1997 |
The in-vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteria.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Erythromycin; Fluoroquinolones; Gram-Positive Bacteria; Lactams; Microbial Sensitivity Tests; Naphthyridines; Vancomycin | 1997 |
Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Endocarditis, Bacterial; Floxacillin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1997 |
[Pneumonia caused by Rhodococcus equi in patients with AIDS: difficulty in defining the most appropriate initial treatment].
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Erythromycin; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rhodococcus equi; Rifampin; Vancomycin | 1997 |
The relationship between the use of flucloxacillin, vancomycin, aminoglycosides and ciprofloxacin and the susceptibility patterns of coagulase-negative staphylococci recovered from blood cultures.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Coagulase; Drug Resistance, Microbial; Floxacillin; Humans; Microbial Sensitivity Tests; Penicillins; Sepsis; Streptococcal Infections; Streptococcus; Vancomycin | 1997 |
Assessment of a standard treatment protocol on visual outcome following presumed bacterial endophthalmitis.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Endophthalmitis; Eye Injuries, Penetrating; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Postoperative Care; Prospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin; Visual Acuity | 1997 |
In vitro activity of the combination of trovafloxacin and other antibiotics against enterococci.
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus; Enterococcus faecalis; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Naphthyridines; Novobiocin; Rifampin; Sulbactam; Teicoplanin; Vancomycin | 1997 |
Susceptibility of different isolates of Vibrio harveyi to antibiotics.
Topics: Animals; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Decapoda; Doxycycline; Drug Resistance, Microbial; Erythromycin; Fish Diseases; Fishes; Microbial Sensitivity Tests; Nalidixic Acid; Nitrofurantoin; Novobiocin; Oxolinic Acid; Oxytetracycline; Penicillins; Seawater; Streptomycin; Sulfonamides; Vancomycin; Vibrio; Vibrio Infections; Water Microbiology | 1997 |
[Enterococci as uropathogens. Frequency of isolation and sensitivity to antibacterial agents].
Topics: Adult; Amikacin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriuria; beta-Lactamases; Child; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Humans; Penicillin Resistance; Penicillins; Streptomycin; Urinary Tract Infections; Vancomycin | 1998 |
Drug resistant enterococci in a south Indian hospital.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gentamicins; Humans; Tetracycline; Vancomycin | 1998 |
In vitro activities of six fluoroquinolones against Canadian isolates of vancomycin-sensitive and vancomycin-resistant Enterococcus species.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Canada; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Vancomycin | 1998 |
[Multicenter trial of Enterococcus antibiotic susceptibility].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Gentamicins; Microbial Sensitivity Tests; Moscow; Penicillins; Russia; Streptomycin; Sulbactam; Vancomycin | 1998 |
Antimicrobial susceptibility of bacteria isolated from orthopedic implants following revision hip surgery.
Topics: Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Bacteria; Cefamandole; Ciprofloxacin; Erythromycin; Humans; Microbial Sensitivity Tests; Vancomycin | 1998 |
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-re
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines; Quinolones; Staphylococcus aureus; Vancomycin; Virginiamycin | 1999 |
Use of a low nutrient culture medium for the identification of bacteria causing severe ocular infection.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Culture Media; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Keratitis; Male; Middle Aged; Propionibacterium acnes; Pseudomonas aeruginosa; Staphylococcus aureus; Vancomycin | 1999 |
Nosocomial meningitis in children after ventriculoperitoneal shunt insertion.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Postoperative Complications; Retrospective Studies; Risk Factors; Vancomycin; Ventriculoperitoneal Shunt | 1999 |
[Severe agranulocytosis induced by carbamazepine (Tegretol)].
Topics: Acinetobacter Infections; Adult; Agranulocytosis; Analgesics, Non-Narcotic; Anti-Bacterial Agents; Anti-Infective Agents; Carbamazepine; Ciprofloxacin; Humans; Male; Quadriplegia; Respiration, Artificial; Vancomycin | 1999 |
Adsorption and release of antibiotics from morselized cancellous bone. In vitro studies of 8 antibiotics.
Topics: Adsorption; Anti-Bacterial Agents; Biological Assay; Bone Transplantation; Cephalosporins; Ciprofloxacin; Clindamycin; Colony Count, Microbial; Drug Carriers; Drug Evaluation, Preclinical; Drug Stability; Humans; Netilmicin; Penicillin G; Rifampin; Temperature; Time Factors; Transplantation, Homologous; Vancomycin | 1999 |
Methicillin resistance among Trinidadian isolates of community and hospital strains of Staphylococcus aureus and their patterns of resistance to non-beta-lactam antibiotics.
Topics: Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Microbial; Erythromycin; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination; Trinidad and Tobago; Vancomycin | 1999 |
Infective endocarditis complicated with progressive heart failure due to beta-lactamase-producing Cardiobacterium hominis.
Topics: Aged; Aortic Valve; Aortic Valve Insufficiency; beta-Lactamases; Ceftriaxone; Ciprofloxacin; Endocarditis, Bacterial; Female; Gram-Negative Bacterial Infections; Gram-Negative Facultatively Anaerobic Rods; Heart Failure; Heart Valve Prosthesis Implantation; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Taiwan; Vancomycin | 2000 |
Antimicrobial-resistant enterococcal isolates from fluoroquinolone-naive children.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child, Preschool; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Fluoroquinolones; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Naphthyridines; Penicillins; Vancomycin | 2000 |
Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Enterococcus faecium; Erythromycin; Humans; Imipenem; Laboratories, Hospital; Meropenem; Ofloxacin; Oxacillin; Penicillins; Pseudomonas aeruginosa; Reproducibility of Results; Serratia marcescens; Staphylococcus aureus; Streptococcus pneumoniae; Thienamycins; Vancomycin | 2000 |
In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Interactions; Humans; Imipenem; Methicillin Resistance; Nisin; Peptides, Cyclic; Rana catesbeiana; Rifampin; Staphylococcus aureus; Vancomycin | 2000 |
A case of costochondral abscess due to Corynebacterium minutissimum in an HIV-infected patient.
Topics: Abscess; Adult; AIDS-Related Opportunistic Infections; Amikacin; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Drug Resistance, Multiple; HIV Infections; HIV-1; Humans; Male; Penicillins; Ribs; Rifampin; Tomography, X-Ray Computed; Vancomycin | 2000 |
Successful use of recombinant tissue plasminogen activator in a patient with relapsing peritonitis.
Topics: Adult; Cefepime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Gentamicins; Humans; Injections, Intraperitoneal; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recombinant Proteins; Recurrence; Remission Induction; Tissue Plasminogen Activator; Vancomycin | 2001 |
Nosocomial pneumonia: importance of recognition of aetiological agents to define an appropriate initial empirical therapy.
Topics: Anti-Bacterial Agents; Bacteria; Blood; Bronchoalveolar Lavage Fluid; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Humans; Lung; Pleural Effusion; Pneumonia, Bacterial; Vancomycin | 2001 |
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.
Topics: Animals; Bacteroides; Ciprofloxacin; Colitis; Enterobacteriaceae; Female; HLA-B27 Antigen; Imipenem; Interleukin-1; Metronidazole; Mice; Mice, Inbred BALB C; Rats; Rats, Inbred F344; Vancomycin | 2001 |
Antimicrobial resistance of Enterococci in Lebanon.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Erythromycin; Gentamicins; Humans; Lebanon; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Rifampin; Streptomycin; Teicoplanin; Tetracycline; Vancomycin | 2001 |
Antimicrobial susceptibility of Listeria monocytogenes isolated from meningoencephalitis in sheep.
Topics: Amoxicillin; Animal Feed; Animals; Anti-Bacterial Agents; Brain; Cephalosporins; Cephalothin; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Gentamicins; Kanamycin; Listeria monocytogenes; Listeriosis; Meningoencephalitis; Microbial Sensitivity Tests; Penicillin G; Penicillins; Rifampin; Sheep; Sheep Diseases; Sulfisoxazole; Tetracycline; Trimethoprim; Vancomycin | 2001 |
Lack of antimicrobial activity of sodium heparin for treating experimental catheter-related infection due to Staphylococcus aureus using the antibiotic-lock technique.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anticoagulants; Catheterization; Ciprofloxacin; Disease Models, Animal; Drug Stability; Drug Synergism; Drug Therapy, Combination; Heparin; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2001 |
Elucidation of antibiotic effectiveness against Staphylococcus epidermidis during intraocular lens implantation.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Adhesion; Ciprofloxacin; Clindamycin; Conjunctiva; Endophthalmitis; Epithelial Cells; Gentamicins; Humans; Lens Implantation, Intraocular; Lenses, Intraocular; Microbial Sensitivity Tests; Postoperative Complications; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2001 |
Drug-induced linear IgA bullous disease following antibiotics.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Arm; Ciprofloxacin; Drug Eruptions; Endocarditis, Bacterial; Female; Foot; Humans; Infusions, Intravenous; Pneumonia; Skin Diseases, Vesiculobullous; Vancomycin | 2001 |
Ciprofloxacin- and methicillin-resistant staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Base Sequence; Ciprofloxacin; Drug Resistance, Multiple; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Moxifloxacin; Ofloxacin; Oxazolidinones; Polymerase Chain Reaction; Quinolines; Sensitivity and Specificity; Staphylococcus aureus; Teicoplanin; Vancomycin | 2001 |
A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Cefuroxime; Cephalosporins; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tibia; Tobramycin; Vancomycin | 2001 |
Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; DNA Gyrase; Drug Resistance, Microbial; Endocarditis, Bacterial; Fluoroquinolones; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rats; Spleen; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2001 |
Resistance to vancomycin, LY333328, ciprofloxacin and trovafloxacin of community-acquired and nosocomial strains of Enterococcus faecalis isolated in Badajoz (Spain) with and without high-level resistance to streptomycin and gentamicin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Enterococcus faecalis; Fluoroquinolones; Gentamicins; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Incidence; Lipoglycopeptides; Microbial Sensitivity Tests; Naphthyridines; Spain; Streptomycin; Vancomycin | 2001 |
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates.
Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma; Quinolines; Streptococcus; Teicoplanin; Thienamycins; Vancomycin | 2002 |
Septic arthritis caused by Chryseobacterium meningosepticum in an immunocompetent male.
Topics: Adolescent; Arthritis, Infectious; beta-Lactamases; Ciprofloxacin; Drug Resistance; Flavobacterium; Humans; Immunocompetence; Joints; Male; Vancomycin; Wounds, Penetrating | 2002 |
Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Lactams; Time Factors; United States; Vancomycin | 2002 |
The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization.
Topics: Ambulatory Care; Antibiotic Prophylaxis; Cefepime; Cephalosporins; Ciprofloxacin; Clarithromycin; Data Collection; Drug Therapy, Combination; Etoposide; Female; Fever; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Neutropenia; Opportunistic Infections; Vancomycin | 2002 |
Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bile; Child; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis; Ciprofloxacin; Enterococcus; Escherichia coli Infections; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Stents; Vancomycin | 2002 |
[Therapeutical, and evolutive particular aspects in cataract surgery].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cataract; Ciprofloxacin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Phacoemulsification; Postoperative Care; Preoperative Care; Treatment Outcome; Vancomycin | 2002 |
In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Ciprofloxacin; Drug Combinations; Fusidic Acid; Gentamicins; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcus aureus; Vancomycin | 2003 |
Formation of Propionibacterium acnes biofilms on orthopaedic biomaterials and their susceptibility to antimicrobials.
Topics: Alloys; Anti-Infective Agents; Bacterial Adhesion; Biocompatible Materials; Biofilms; Bone Cements; Cefamandole; Ciprofloxacin; Gentamicins; Hip Prosthesis; In Vitro Techniques; Polymethyl Methacrylate; Propionibacterium acnes; Time Factors; Titanium; Vancomycin | 2003 |
[Meningitis caused by multiresistant E. coli after an echo-directed transrectal biopsy].
Topics: Aged; Amoxicillin; Biopsy; Brain Damage, Chronic; Cefepime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Confusion; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Male; Meningitis, Bacterial; Premedication; Prostate; Rectum; Ultrasonography; Vancomycin | 2003 |
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Floxacillin; Fluoroquinolones; Infusions, Intravenous; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rats; Staphylococcal Infections; Streptococcal Infections; Vancomycin; Viridans Streptococci | 2004 |
[Synthesis and in vitro antibacterial activities of new 3,5-disubstituted oxazolidinone compounds].
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Staphylococcus aureus; Streptococcus; Structure-Activity Relationship; Sulbactam; Vancomycin | 2003 |
An in vitro study on the compatibility and precipitation of a combination of ciprofloxacin and vancomycin in human vitreous.
Topics: Aged; Body Temperature; Chemical Precipitation; Chromatography, High Pressure Liquid; Ciprofloxacin; Dialysis; Drug Interactions; Drug Stability; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Sodium Chloride; Vancomycin; Vitreous Body | 2004 |
[Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
Topics: Acetamides; Anti-Infective Agents; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Gentamicins; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2003 |
[Recurrence of bacterial endophthalmitis after penetrating keratoplasty].
Topics: Abscess; Adult; Amphotericin B; Aqueous Humor; Candida albicans; Candidiasis; Ciprofloxacin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Infections, Fungal; Humans; Keratoplasty, Penetrating; Male; Postoperative Complications; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Vitreous Body | 2004 |
Determination of minimal regrowth concentration (MRC) in clinical isolates of various biofilm-forming bacteria.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Adhesion; Biofilms; Chloramphenicol; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Escherichia coli; Klebsiella pneumoniae; Lactams; Microbial Sensitivity Tests; Netilmicin; Predictive Value of Tests; Pseudomonas aeruginosa; Staphylococcus; Teicoplanin; Tetracycline; Vancomycin | 2004 |
Ciprofloxacin in endophthalmitis: an emerging alternative.
Topics: Anti-Infective Agents; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Humans; Microbial Sensitivity Tests; Vancomycin | 2004 |
Plasmids of Staphylococcus cohnii isolated from the intensive-care unit.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Bacteriocins; Chloramphenicol; Ciprofloxacin; Clindamycin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Gentamicins; Hospitals, Pediatric; Intensive Care Units; Microbial Sensitivity Tests; Molecular Epidemiology; Mupirocin; Plasmids; Poland; Staphylococcus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2004 |
Effects of sarA inactivation on the intrinsic multidrug resistance mechanism of Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Ethidium; Mutation; Staphylococcus aureus; Trans-Activators; Vancomycin | 2004 |
Chryseobacterium meningosepticum infections in a dialysis unit.
Topics: Chryseobacterium; Ciprofloxacin; Cross Infection; Equipment Contamination; Flavobacteriaceae Infections; Hemodialysis Units, Hospital; Hospitals, General; Hospitals, Teaching; Humans; Peritoneal Dialysis; Peritonitis; Retrospective Studies; Sepsis; Sri Lanka; Vancomycin | 2004 |
Use of simulated blood cultures for antibiotic effect on time to detection of the two blood culture systems BacT/ALERT and BACTEC 9240.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Bacteria; Bacteriological Techniques; Blood; Cefotaxime; Ciprofloxacin; Culture Media; Enterococcus faecalis; Escherichia coli; Gentamicins; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2004 |
Treatment of experimental osteomyelitis by liposomal antibiotics.
Topics: Animals; Anti-Bacterial Agents; Chronic Disease; Ciprofloxacin; Drug Carriers; Drug Therapy, Combination; Humans; Liposomes; Microbial Sensitivity Tests; Osteomyelitis; Rabbits; Sonication; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2004 |
Community-acquired methicillin-resistant Staphylococcus aureus prostatic abscess.
Topics: Abscess; Adult; Bacteremia; Ciprofloxacin; Combined Modality Therapy; Community-Acquired Infections; Disease Susceptibility; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Hepatitis C; Humans; Male; Methicillin Resistance; Nafcillin; Orchitis; Prostatitis; Recurrence; Staphylococcal Infections; Staphylococcus aureus; Substance Abuse, Intravenous; Suppuration; Transurethral Resection of Prostate; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2004 |
[Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Topics: Anti-Bacterial Agents; Child; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gentamicins; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Penicillins; Poland; Streptomycin; Teicoplanin; Tetracycline; Urinary Tract Infections; Vancomycin | 2004 |
Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Fluoroquinolones; Keratitis; Methicillin Resistance; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2005 |
[Methicillin-resistant Staphylococcus aureus (MRSA) -- case report].
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cholangitis; Ciprofloxacin; Humans; Male; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2005 |
Mycobacterium simiae: a previously undescribed pathogen in peritoneal dialysis peritonitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Amoxicillin; Antiretroviral Therapy, Highly Active; Candidiasis, Oral; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Equipment Contamination; Gentamicins; Humans; Immunocompromised Host; Kidney Failure, Chronic; Male; Mycobacterium; Mycobacterium Infections; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Pneumonia, Pneumocystis; Renal Dialysis; Rifabutin; Vancomycin | 2005 |
Identification of Lactobacillus ruminus SPM0211 isolated from healthy Koreans and its antimicrobial activity against some pathogens.
Topics: Adult; Base Sequence; Ciprofloxacin; DNA Fingerprinting; Drug Resistance, Bacterial; Enterococcus; Ethambutol; Feces; Humans; Korea; Lactobacillus; Microbial Sensitivity Tests; Molecular Sequence Data; Probiotics; Random Amplified Polymorphic DNA Technique; Rifampin; Staphylococcus aureus; Streptomycin; Time Factors; Vancomycin | 2005 |
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Catheters, Indwelling; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Linezolid; Male; Oxazolidinones; Plankton; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Virginiamycin | 2005 |
Endophthalmitis after microincision cataract surgery.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Humans; Intraocular Pressure; Male; Microbial Sensitivity Tests; Microsurgery; Middle Aged; Phacoemulsification; Postoperative Complications; Streptococcal Infections; Streptococcus; Vancomycin; Vitrectomy | 2005 |
RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Biofilms; Catheterization, Central Venous; Catheters, Indwelling; Ciprofloxacin; Drug Therapy, Combination; Imipenem; Male; Microbial Sensitivity Tests; Oligopeptides; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
3-Bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives as new lead compounds for antibacterially active substances.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests; Mycobacterium smegmatis; Pyrroles; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin | 2006 |
Comparative in vitro efficacies of various catheter lock solutions.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anticoagulants; Candida albicans; Catheterization; Catheters, Indwelling; Ciprofloxacin; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Edetic Acid; Ethanol; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Pharmaceutical Preparations; Pseudomonas aeruginosa; Rifampin; Solutions; Staphylococcus aureus; Staphylococcus epidermidis; Taurine; Thiadiazines; Time Factors; Vancomycin | 2006 |
Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple; Erythromycin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Penicillins; Population Surveillance; Portugal; Retrospective Studies; Serotyping; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2006 |
Ciprofloxacin treatment of bacterial peritonitis associated with chronic ambulatory peritoneal dialysis caused by Neisseria cinerea.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Gentamicins; Humans; Kidney Failure, Chronic; Male; Neisseria cinerea; Neisseriaceae Infections; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Vancomycin | 2006 |
Interleukin-1, interleukin-6, and interleukin-10 responses after antibiotic treatment in experimental chronic Staphylococcus aureus osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cefuroxime; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Interleukin-1; Interleukin-10; Interleukin-6; Interleukins; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Tibia; Tobramycin; Vancomycin | 2006 |
Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy.
Topics: Anti-Bacterial Agents; Anticoagulants; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Ciprofloxacin; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Heparin; Humans; Treatment Outcome; Vancomycin | 2006 |
Dendritiform cells found in central cornea by in-vivo confocal microscopy in a patient with mixed bacterial keratitis.
Topics: Adult; Bacteria; Ciprofloxacin; Contact Lenses, Hydrophilic; Dendritic Cells; Drug Therapy, Combination; Epithelium, Corneal; Eye Infections, Bacterial; Humans; Keratitis; Male; Microscopy, Confocal; Vancomycin | 2006 |
Chryseobacterium meningosepticum infection and cardiac tamponade in a long-term hemodialysis patient.
Topics: Aged; Anti-Bacterial Agents; Cardiac Tamponade; Chryseobacterium; Ciprofloxacin; Fatal Outcome; Flavobacteriaceae Infections; Humans; Kidney Failure, Chronic; Male; Meropenem; Pericarditis; Renal Dialysis; Thienamycins; Vancomycin | 2006 |
Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefazolin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Critical Pathways; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Preoperative Care; Skin Tests; Treatment Outcome; Vancomycin | 2006 |
Bilateral methicillin-resistant Staphylococcus aureus keratitis after photorefractive keratectomy.
Topics: Ciprofloxacin; Eye Infections, Bacterial; Female; Humans; Keratitis; Lasers, Excimer; Methicillin Resistance; Middle Aged; Photorefractive Keratectomy; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2007 |
Antibiotics for local delivery systems cause skeletal cell toxicity in vitro.
Topics: 3T3 Cells; Animals; Anti-Bacterial Agents; Biocompatible Materials; Bone Cements; Cell Count; Cell Membrane; Cell Movement; Cell Survival; Chondrocytes; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Delivery Systems; L-Lactate Dehydrogenase; Mice; Osteoblasts; Tobramycin; Vancomycin | 2007 |
Antibacterial activation of hydroxyapatite (HA) with controlled porosity by different antibiotics.
Topics: Adsorption; Anti-Bacterial Agents; Biocompatible Materials; Ciprofloxacin; Durapatite; Escherichia coli; Gentamicins; Humans; Microbial Sensitivity Tests; Particle Size; Pilot Projects; Porosity; Staphylococcus aureus; Staphylococcus epidermidis; Surface Properties; Vancomycin | 2007 |
Five day antibiotic prophylaxis for major lower limb amputation reduces wound infection rates and the length of in-hospital stay.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ciprofloxacin; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; England; Female; Floxacillin; Gentamicins; Humans; Length of Stay; Lower Extremity; Male; Medical Audit; Metronidazole; Middle Aged; Prospective Studies; Reoperation; Retrospective Studies; Surgical Wound Infection; Treatment Outcome; Vancomycin | 2008 |
[Clinical cases in Medical Mycology. Case No. 29].
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Arthritis, Infectious; Bacteremia; Ciprofloxacin; Combined Modality Therapy; Debridement; Drainage; Drug Therapy, Combination; Glomerulonephritis; Humans; Immunocompromised Host; Itraconazole; Lymphangitis; Male; Mycetoma; Psoas Abscess; Scedosporium; Staphylococcal Infections; Vancomycin | 2007 |
Antibiotic resistance of enterococci in American bison (Bison bison) from a nature preserve compared to that of Enterococci in pastured cattle.
Topics: Ampicillin; Animals; Bacteriocins; Biodiversity; Bison; Cattle; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Feces; Gelatinases; Hemolysin Proteins; Phenotype; Tetracycline; Vancomycin | 2008 |
Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; Genes, Bacterial; Gentamicins; Metronidazole; Microbial Sensitivity Tests; Mutation; Rifampin; Sulfamethoxazole; Vancomycin | 2008 |
Polyester vascular prostheses coated with a cyclodextrin polymer and activated with antibiotics: cytotoxicity and microbiological evaluation.
Topics: Anti-Bacterial Agents; Blood Vessel Prosthesis; Cell Survival; Cellulose; Ciprofloxacin; Cyclodextrins; Enterococcus; Escherichia coli; Humans; Microbial Sensitivity Tests; Polyesters; Prosthesis Design; Rifampin; Spectrophotometry; Staphylococcus aureus; Vancomycin | 2008 |
High-strength resorbable brushite bone cement with controlled drug-releasing capabilities.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Bone Cements; Calcium Phosphates; Ciprofloxacin; Citric Acid; Drug Delivery Systems; Microscopy, Electron, Scanning; Models, Chemical; Particle Size; Powders; Pressure; Stress, Mechanical; Vancomycin | 2009 |
Occurrence of ciprofloxacin-, trimethoprim-sulfamethoxazole-, and vancomycin-resistant bacteria in a municipal wastewater treatment plant.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterococcus; Escherichia coli; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Waste Disposal, Fluid; Water Microbiology | 2009 |
sarA inactivation reduces vancomycin-intermediate and ciprofloxacin resistance expression by Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Gene Deletion; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Microbial Sensitivity Tests; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Prolonged local antibiotics delivery from hydroxyapatite functionalised with cyclodextrin polymers.
Topics: 3T3 Cells; Animals; Anti-Infective Agents; Bone Transplantation; Ciprofloxacin; Cyclodextrins; Drug Delivery Systems; Durapatite; Humans; Kinetics; Mice; Polymers; Staphylococcus aureus; Vancomycin | 2009 |
Comparative activity of oritavancin against meticillin-resistant Staphylococcus aureus (MRSA) bloodstream isolates from Geneva University Hospital.
Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Erythromycin; Glycopeptides; Hospitals, Teaching; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections; Switzerland; Vancomycin | 2009 |
Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE.
Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Ciprofloxacin; Daptomycin; Enterococcus; Female; Fever; Humans; Incidence; Linezolid; Male; Middle Aged; Neutropenia; Oxazolidinones; Retrospective Studies; Vancomycin; Vancomycin Resistance | 2010 |
Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Bacterial; Eye Infections, Bacterial; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 2010 |
[Prevalence of Clostridium difficile in the gastrointestinal tract of hospitalized children under two years of age].
Topics: Aza Compounds; Ciprofloxacin; Clindamycin; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Female; Fluoroquinolones; Gastrointestinal Tract; Gatifloxacin; Genotype; Humans; Infant; Infant, Newborn; Male; Metronidazole; Moxifloxacin; Phenotype; Quinolines; Species Specificity; Vancomycin | 2010 |
MRT letter: Spatial distribution of vancomycin-induced damage in Staphylococcus epidermidis biofilm: an electron microscopic study.
Topics: Amikacin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Humans; Microscopy, Electron, Scanning; Staphylococcus epidermidis; Vancomycin | 2010 |
Bordetella bronchiseptica bacteremia in a patient with AIDS.
Topics: Adult; AIDS-Associated Nephropathy; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Bacteremia; Bordetella bronchiseptica; Bordetella Infections; Catheter-Related Infections; Ciprofloxacin; Gentamicins; Humans; Male; Renal Dialysis; Vancomycin | 2010 |
Bone implants modified with cyclodextrin: study of drug release in bulk fluid and into agarose gel.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Anti-Bacterial Agents; beta-Cyclodextrins; Bone Substitutes; Calorimetry, Differential Scanning; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Delivery Systems; Drug Stability; Durapatite; Gels; Kinetics; Sepharose; Vancomycin | 2010 |
In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents.
Topics: Amphotericin B; Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Doxycycline; Erythromycin; Fluorouracil; Fosfomycin; Leptospira; Microbial Sensitivity Tests; Neomycin; Philippines; Rats; Sulfamethoxazole; Trimethoprim; Vancomycin | 2010 |
Influence of ciprofloxacin and vancomycin on mutation rate and transposition of IS256 in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; DNA Transposable Elements; Mutation; Recombination, Genetic; Sigma Factor; SOS Response, Genetics; Staphylococcus aureus; Vancomycin | 2011 |
Management of an extensive spinal epidural abscess from C-1 to the sacrum. Case report.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Epidural Abscess; Female; Humans; Laminectomy; Spine; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2010 |
Large leg ulcers due to autoimmune diseases.
Topics: Animals; Antibodies, Monoclonal; Autoimmune Diseases; Azathioprine; Ciprofloxacin; Cyclophosphamide; Cyclosporine; Female; Humans; Hydroxychloroquine; Hyperbaric Oxygenation; Infliximab; Larva; Leg Ulcer; Male; Methylprednisolone; Middle Aged; Prednisolone; Skin Transplantation; Treatment Outcome; Vancomycin; Vasculitis; Young Adult | 2011 |
Impact of evaluating antibiotic concentrations in abdominal abscesses percutaneously drained.
Topics: Abdominal Abscess; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Exudates and Transudates; Female; Fluconazole; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Suction; Treatment Outcome; Vancomycin | 2011 |
Rhodococcus equi infection after lung transplantation.
Topics: Actinomycetales Infections; Anti-Bacterial Agents; Ciprofloxacin; Humans; Immunity, Cellular; Immunocompromised Host; Lung Transplantation; Male; Middle Aged; Postoperative Complications; Pulmonary Disease, Chronic Obstructive; Rhodococcus equi; Solitary Pulmonary Nodule; Tomography, X-Ray Computed; Transplantation, Homologous; Vancomycin | 2011 |
In vitro potentiation of ampicillin, oxacillin, norfloxacin, ciprofloxacin, and vancomycin by sanguinarine against methicillin-resistant Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Load; Benzophenanthridines; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Isoquinolines; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Norfloxacin; Oxacillin; Species Specificity; Vancomycin | 2011 |
Fluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Biopsy; Carbapenems; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatitis; Retrospective Studies; Vancomycin | 2012 |
Characterization of the mechanisms of fluoroquinolone resistance in vancomycin-resistant enterococci of different origins.
Topics: Ampicillin; Anti-Infective Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Enterococcus; Fluoroquinolones; Genes, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Mutation; Vancomycin | 2011 |
Activity of vancomycin, ciprofloxacin, daptomycin, and linezolid against coagulase-negative staphylococci bacteremia.
Topics: Acetamides; Bacteremia; Catheter-Related Infections; Ciprofloxacin; Cross Infection; Daptomycin; Drug Resistance, Multiple, Bacterial; Hospital Departments; Hospitals, University; Humans; Length of Stay; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Spain; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Staphylococcus hominis; Vancomycin | 2011 |
Infectious scleritis after subtenon triamcinolone acetonide injection.
Topics: Administration, Topical; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Corneal Transplantation; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Injections, Intraocular; Male; Necrosis; Ophthalmic Solutions; Scleritis; Staphylococcal Infections; Staphylococcus epidermidis; Tenon Capsule; Triamcinolone Acetonide; Vancomycin; Young Adult | 2011 |
Measurement of trace levels of antibiotics in river water using on-line enrichment and triple-quadrupole LC-MS/MS.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, Liquid; Ciprofloxacin; Erythromycin; Fluoroquinolones; Hydrogen-Ion Concentration; Norfloxacin; Ofloxacin; Oxolinic Acid; Reproducibility of Results; Rivers; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Tetracycline; Trimethoprim; Tylosin; Vancomycin; Water Pollutants, Chemical | 2011 |
Epidemiologic characteristics of resistant microorganisms present in reserves from an intensive care unit.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Equipment Contamination; Humans; Intensive Care Units; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin; Vancomycin Resistance | 2012 |
[Influence of inoculum size on MICs for methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus].
Topics: Acetamides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Cefazolin; Ciprofloxacin; Dibekacin; Drug Resistance, Bacterial; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Teicoplanin; Thienamycins; Vancomycin | 2011 |
Safety, healing, and efficacy of vascular prostheses coated with hydroxypropyl-β-cyclodextrin polymer: experimental in vitro and animal studies.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; Anti-Bacterial Agents; beta-Cyclodextrins; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Ciprofloxacin; Coated Materials, Biocompatible; Dogs; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemolysis; Humans; In Vitro Techniques; Methicillin-Resistant Staphylococcus aureus; Mice; Platelet Aggregation; Prosthesis-Related Infections; Rifampin; Toxicity Tests; Treatment Outcome; Vancomycin; Wound Healing | 2012 |
In vitro activities of nisin alone or in combination with vancomycin and ciprofloxacin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains.
Topics: Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Nisin; Staphylococcus aureus; Vancomycin | 2011 |
Critical appraisal of air pouch infection model in rats.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Exudates and Transudates; Female; Gentamicins; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rats; Rats, Wistar; Staphylococcus aureus; Vancomycin | 2012 |
Comparative assessment of antimicrobial usage measures in the Department of Veterans Affairs.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Utilization Review; Hospitals, Veterans; Humans; Imipenem; Meropenem; Penicillanic Acid; Pilot Projects; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins; United States; Vancomycin | 2012 |
Adjunctive antibiotics in the treatment of acute bacterial endophthalmitis following cataract surgery.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Bacteria; Cataract Extraction; Ciprofloxacin; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Postoperative Complications; Quinolines; Retrospective Studies; Vancomycin; Visual Acuity; Vitreous Body | 2012 |
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Ciprofloxacin; Critical Illness; Female; Hemofiltration; Humans; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins; Vancomycin | 2012 |
Comparison of the WST-8 colorimetric method and the CLSI broth microdilution method for susceptibility testing against drug-resistant bacteria.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Ciprofloxacin; Colorimetry; Culture Media; Enterococcus faecalis; Haemophilus influenzae; Indicator Dilution Techniques; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Microbial Viability; Pseudomonas aeruginosa; Vancomycin; Vancomycin Resistance | 2012 |
Antimicrobial resistance profiles of Enterococcus faecalis and Enterococcus faecium isolated from artisanal food of animal origin in Argentina.
Topics: Animals; Anti-Bacterial Agents; Argentina; Bacterial Proteins; beta-Lactamases; Carbon-Oxygen Ligases; Cattle; Ciprofloxacin; Dairy Products; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Food Contamination; Food Microbiology; Genotype; Gentamicins; Goats; Meat Products; Microbial Sensitivity Tests; Penicillins; Phenotype; Streptomycin; Teicoplanin; Vancomycin | 2012 |
[Microbiological monitoring in therapy of patients with iatrogenic esophageotracheal fistula].
Topics: Acetamides; Anti-Bacterial Agents; Candida; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Iatrogenic Disease; Imipenem; Intubation, Intratracheal; Linezolid; Microbial Sensitivity Tests; Monitoring, Physiologic; Oxazolidinones; Polymyxin B; Pseudomonas aeruginosa; Respiratory Tract Infections; Staphylococcus aureus; Staphylococcus epidermidis; Tracheoesophageal Fistula; Vancomycin | 2012 |
Antibiotic susceptibility of periodontal Enterococcus faecalis.
Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; Chronic Periodontitis; Ciprofloxacin; Clindamycin; Dental Plaque; Drug Resistance, Bacterial; Enterococcus faecalis; Erythromycin; Female; Gingiva; Gram-Positive Bacterial Infections; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Periodontal Pocket; Periodontitis; Teicoplanin; Tetracycline Resistance; Vancomycin | 2013 |
Genotypic diversity, antibiotic resistance and bacteriocin production of enterococci isolated from rhizospheres.
Topics: Bacteriocins; Biodiversity; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Erythromycin; Genetic Variation; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plant Roots; Rhizosphere; Tetracycline; Tetracycline Resistance; Vancomycin; Vancomycin Resistance | 2012 |
Phenotypic and molecular antibiotic resistance profile of Enterococcus faecalis and Enterococcus faecium isolated from different traditional fermented foods.
Topics: Ampicillin; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Fermentation; Food Contamination; Food Microbiology; Genes, Bacterial; Gentamicins; Levofloxacin; Microbial Sensitivity Tests; Nitrofurantoin; Ofloxacin; Penicillins; Phenotype; Vancomycin | 2013 |
High abundance and diversity of antimicrobial resistance determinants among early vancomycin-resistant Enterococcus faecium in Poland.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Gentamicins; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Poland; Streptomycin; Tetracycline; Vancomycin; Vancomycin Resistance | 2013 |
Methicillin-resistant coagulase-negative staphylococci (MRCoNS) by disk diffusion method.
Topics: Anti-Bacterial Agents; Ceftriaxone; Cefuroxime; Ciprofloxacin; Coagulase; Drug Resistance, Multiple, Bacterial; Exudates and Transudates; Gentamicins; Humans; Imipenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Suppuration; Surgical Wound Infection; Vancomycin | 2013 |
Neck abscess associated with a piriform fossa sinus tract in an adult.
Topics: Abscess; Adult; Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Humans; Hypopharynx; Male; Neck; Pyriform Sinus; Staphylococcal Infections; Staphylococcus aureus; Tomography, X-Ray Computed; Treatment Outcome; Vancomycin | 2013 |
Molecular characterization and antibiotic resistance of clinical isolates of methicillin-resistant Staphylococcus aureus obtained from Southeast of Iran (Kerman).
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Child; Child, Preschool; Ciprofloxacin; Clindamycin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Exotoxins; Gentamicins; Humans; Infant; Iran; Leukocidins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Micrococcal Nuclease; Middle Aged; Oxazolidinones; Penicillin-Binding Proteins; Phenotype; Prevalence; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Young Adult | 2014 |
Lower extremities and iliopsoas pyomyositis with concurrent septic arthritis and spinal epidural abscess in a diabetic patient.
Topics: Arthritis, Infectious; Benzoyl Peroxide; Ciprofloxacin; Clindamycin; Drug Combinations; Epidural Abscess; Humans; Magnetic Resonance Imaging; Male; Pyomyositis; Staphylococcal Infections; Thigh; Vancomycin | 2013 |
Comparison of Sensititre microdilution method to other standard methods for susceptibility testing of coagulase-negative staphylococci from paediatric blood cultures.
Topics: Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clindamycin; Daptomycin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Oxacillin; Staphylococcus epidermidis; Staphylococcus hominis; Tetracycline; Vancomycin | 2014 |
Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Ciprofloxacin; Colistin; Daptomycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fosfomycin; In Vitro Techniques; Klebsiella pneumoniae; Lipoglycopeptides; Meropenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Thienamycins; Tigecycline; Vancomycin | 2014 |
Prevention of Clostridium difficile spore formation by sub-inhibitory concentrations of tigecycline and piperacillin/tazobactam.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clostridioides difficile; Humans; Metronidazole; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Ribotyping; Spores, Bacterial; Tazobactam; Tigecycline; Vancomycin | 2014 |
Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Candidiasis; Cefepime; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Ciprofloxacin; Consolidation Chemotherapy; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Incidence; Induction Chemotherapy; Infant; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Neoplasm Staging; Nose; Outpatients; Rectum; Retrospective Studies; Treatment Outcome; Vancomycin; Young Adult | 2014 |
Microbacterium spp. as a cause of peritoneal-dialysis-related peritonitis in two patients.
Topics: Acinetobacter; Actinobacteria; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Penicillins; Peritoneal Dialysis; Peritonitis; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vancomycin | 2016 |
Increased release time of antibiotics from bone allografts through a novel biodegradable coating.
Topics: Allografts; Amoxicillin; Biocompatible Materials; Bone Transplantation; Chitosan; Ciprofloxacin; Humans; Infections; Polymers; Vancomycin | 2014 |
Impact of antibiotics with various target sites on the metabolome of Staphylococcus aureus.
Topics: Ampicillin; Anti-Bacterial Agents; Cell Wall; Ciprofloxacin; Erythromycin; Fosfomycin; Metabolic Networks and Pathways; Metabolome; Peptidoglycan; Staphylococcus aureus; Vancomycin | 2014 |
Three new carbazole alkaloids and biological activities of Murraya koenigii.
Topics: Alkaloids; Anti-Bacterial Agents; Carbazoles; Ciprofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Murraya; Nuclear Magnetic Resonance, Biomolecular; Pakistan; Plant Leaves; Vancomycin | 2015 |
Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Floxacillin; Follow-Up Studies; Genome, Bacterial; Gentamicins; Humans; Liver Diseases; Male; Meropenem; Middle Aged; Sequence Analysis, DNA; Soft Tissue Infections; Thienamycins; Treatment Outcome; Vancomycin | 2014 |
Endogenous endophthalmitis in a patient with diabetes and foot osteomyelitis.
Topics: Aged; Anti-Bacterial Agents; Ciprofloxacin; Diabetes Complications; Diabetes Mellitus; Endophthalmitis; Female; Foot Diseases; Humans; Imipenem; Osteomyelitis; Radiography; Vancomycin | 2015 |
Study of the Influence of Bone Cement Type and Mixing Method on the Bioactivity and the Elution Kinetics of Ciprofloxacin.
Topics: Anti-Bacterial Agents; Bone Cements; Ciprofloxacin; Drug Combinations; Drug Delivery Systems; Humans; Kinetics; Methylmethacrylates; Polymethyl Methacrylate; Polystyrenes; Solubility; Temperature; Vancomycin | 2015 |
Case of antibiotic-associated diarrhea caused by Staphylococcus aureus enterocolitis.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Clostridioides difficile; Diagnosis, Differential; Enterocolitis; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Vancomycin | 2015 |
RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria.
Topics: Anti-Bacterial Agents; Ceftazidime; Cells, Cultured; Ciprofloxacin; Daptomycin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Guanidines; Humans; Microbial Sensitivity Tests; Monocytes; Moxifloxacin; Protein Synthesis Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Pyrimidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2015 |
Catalase Expression Is Modulated by Vancomycin and Ciprofloxacin and Influences the Formation of Free Radicals in Staphylococcus aureus Cultures.
Topics: Catalase; Ciprofloxacin; Culture Media; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Free Radicals; Humans; Hydrogen Peroxide; Hydroxyl Radical; Iron; Oxidation-Reduction; Staphylococcus aureus; Vancomycin | 2015 |
Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.
Topics: Aged; Aged, 80 and over; Amikacin; Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Escherichia coli; Female; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Japan; Klebsiella oxytoca; Klebsiella pneumoniae; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Proteus mirabilis; Pseudomonas aeruginosa; Serratia marcescens; Urinary Tract Infections; Vancomycin | 2015 |
Antimicrobial susceptibility and the in vitro postantibiotic effects of vancomycin and ciprofloxacin against Bacillus cereus isolates.
Topics: Anti-Bacterial Agents; Bacillus cereus; Ciprofloxacin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Vancomycin | 2016 |
Detection of antibiotic resistance in probiotics of dietary supplements.
Topics: Aztreonam; Bacteria; Ciprofloxacin; Dietary Supplements; Drug Resistance, Bacterial; Food Microbiology; Gentamicins; Lactobacillus; Pilot Projects; Probiotics; Streptomycin; Vancomycin | 2015 |
Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacteremia; Ciprofloxacin; Clarithromycin; Disease Models, Animal; Doxycycline; Drug Combinations; Drug Synergism; Humans; Imipenem; Linezolid; Male; Microbial Sensitivity Tests; Rabbits; Respiratory Tract Infections; Rifampin; Spores, Bacterial; Survival Analysis; Vancomycin | 2015 |
Rhodococcus equi peritonitis in continuous ambulatory peritoneal dialysis: a first in Australia.
Topics: Actinomycetales Infections; Adult; Anti-Infective Agents; Australia; Azithromycin; Ciprofloxacin; Drug Therapy, Combination; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Rhodococcus equi; Treatment Outcome; Vancomycin | 2015 |
Influence of antibiotic pressure on bacterial bioluminescence, with emphasis on Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Erythromycin; Escherichia coli; Luciferases, Bacterial; Luminescence; Luminescent Measurements; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; Staphylococcus aureus; Vancomycin | 2015 |
Antibiotic Susceptibility of Biofilm Cells and Molecular Characterisation of Staphylococcus hominis Isolates from Blood.
Topics: Amidohydrolases; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Biofilms; Cefoxitin; Chromosomes, Bacterial; Ciprofloxacin; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Humans; Methicillin; Microbial Sensitivity Tests; Operon; Oxacillin; Penicillin-Binding Proteins; Phylogeny; Plankton; Staphylococcal Infections; Staphylococcus hominis; Vancomycin | 2015 |
Can physicochemical properties of antimicrobials be used to predict their pharmacokinetics during extracorporeal membrane oxygenation? Illustrative data from ovine models.
Topics: Animals; Anti-Infective Agents; Carbapenems; Caspofungin; Ceftriaxone; Ciprofloxacin; Critical Illness; Doripenem; Echinocandins; Extracorporeal Membrane Oxygenation; Fluconazole; Gentamicins; Lipopeptides; Meropenem; Models, Theoretical; Sheep; Sheep, Domestic; Thienamycins; Vancomycin | 2015 |
Exploring Synergy between Classic Mutagens and Antibiotics To Examine Mechanisms of Synergy and Antibiotic Action.
Topics: 2-Aminopurine; 4-Nitroquinoline-1-oxide; Anti-Bacterial Agents; Azacitidine; Bromodeoxyuridine; Chloramphenicol; Ciprofloxacin; Cytidine; DNA Breaks, Double-Stranded; Drug Synergism; Erythromycin; Escherichia coli; Gentamicins; Microbial Sensitivity Tests; Mutagens; Tetracycline; Trimethoprim; Vancomycin | 2015 |
SYSTEMIC ORAL ANTIBIOTICS AS A PROPHYLACTIC MEASURE TO PREVENT ENDOPHTHALMITIS IN PATIENTS WITH OPEN GLOBE INJURIES IN COMPARISON WITH INTRAVENOUS ANTIBIOTICS.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftazidime; Ciprofloxacin; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Vancomycin; Visual Acuity; Young Adult | 2016 |
Prevalence and antimicrobial susceptibility profiles of Staphylococcus aureus nasal carriage among pre-clinical and clinical medical students in a Tanzanian University.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Carrier State; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nasal Cavity; Prevalence; Staphylococcal Infections; Students, Medical; Tanzania; Universities; Vancomycin | 2016 |
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult | 2016 |
Observations of resistance through minimum inhibitory concentrations trends for respiratory specimens of commonly isolated organisms.
Topics: Acinetobacter; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Respiratory Tract Infections; Retrospective Studies; Staphylococcus aureus; Vancomycin | 2016 |
Antibiofilm Activity and Synergistic Inhibition of Staphylococcus aureus Biofilms by Bactericidal Protein P128 in Combination with Antibiotics.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Daptomycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gentamicins; Linezolid; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Recombinant Fusion Proteins; Staphylococcus aureus; Vancomycin | 2016 |
Two Clusters of Fluoroquinolone and Clindamycin-Resistant Clostridium difficile PCR Ribotype 001 Strain Recognized by Capillary Electrophoresis Ribotyping and Multilocus Variable Tandem Repeat Analysis.
Topics: Aged; Amino Acid Substitution; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Clostridioides difficile; Clostridium Infections; Czech Republic; DNA Gyrase; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Capillary; Female; Fluoroquinolones; Gene Expression; Humans; Male; Methyltransferases; Metronidazole; Microbial Sensitivity Tests; Minisatellite Repeats; Moxifloxacin; Multilocus Sequence Typing; Retrospective Studies; Ribotyping; Tertiary Care Centers; Vancomycin | 2017 |
Phenotypic and genetic characterization of multidrug-resistant Staphylococcus aureus in the tropics of Southeast Asia.
Topics: Anti-Bacterial Agents; Asia, Southeastern; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Genotype; Gentamicins; Hospitals; Microbial Sensitivity Tests; Phenotype; Staphylococcus aureus; Vancomycin; Wastewater | 2016 |
Hyperosmotic Agents and Antibiotics Affect Dissolved Oxygen and pH Concentration Gradients in Staphylococcus aureus Biofilms.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Combined Modality Therapy; Honey; Hydrogen-Ion Concentration; Iodophors; Microbial Sensitivity Tests; Osmotic Pressure; Oxygen; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Wounds and Injuries | 2017 |
Characterization of Antibiotic Resistance Genes from Lactobacillus Isolated from Traditional Dairy Products.
Topics: Anti-Bacterial Agents; China; Ciprofloxacin; Cultured Milk Products; Drug Resistance, Bacterial; Fermentation; Food Microbiology; Gene Transfer, Horizontal; Genes, Bacterial; Humans; Lactobacillus; Microbial Sensitivity Tests; Probiotics; Tetracycline; Vancomycin | 2017 |
Semi-quantitative MALDI-TOF for antimicrobial susceptibility testing in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Oxacillin; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2017 |
Evaluation of combinations of putative anti-biofilm agents and antibiotics to eradicate biofilms of Staphylococcus aureus and Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Clindamycin; Deoxyribonuclease I; Gentamicins; Humans; Hydrogen Peroxide; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Soaps; Staphylococcus aureus; Vancomycin | 2017 |
Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantation.
Topics: Adult; Anti-Bacterial Agents; Azathioprine; Cholangitis, Sclerosing; Ciprofloxacin; Drug Therapy, Combination; Humans; Liver Function Tests; Liver Transplantation; Male; Postoperative Complications; Prednisolone; Recurrence; Treatment Outcome; Vancomycin | 2017 |
Antimicrobial resistance of Enterococcus spp. isolated from Thai fermented pork in Chiang Rai Province, Thailand.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Enterococcus; Fermented Foods; Macrolides; Meat; Microbial Sensitivity Tests; Swine; Thailand; Vancomycin | 2018 |
Microbial contaminants isolated from items and work surfaces in the post- operative ward at Kawolo general hospital, Uganda.
Topics: Anti-Bacterial Agents; Bedding and Linens; Ceftriaxone; Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Bacteria; Hospitals, General; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Operating Tables; Staphylococcus aureus; Surgical Attire; Surgical Equipment; Uganda; Vancomycin | 2018 |
Brought Down by a Mosquito? West Nile Virus Encephalitis.
Topics: Acyclovir; Anti-Infective Agents; Brain; Ceftriaxone; Ciprofloxacin; Consciousness Disorders; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paresis; Vancomycin; West Nile Fever; West Nile virus | 2018 |
Highly antibiotic-resistant Clostridium difficile isolates from Iranian patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Iran; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2018 |
Effects of Vancomycin and Ciprofloxacin on the NMRI Mouse Metabolism.
Topics: Animals; Anti-Bacterial Agents; Body Fluids; Brain; Ciprofloxacin; Female; Gastrointestinal Microbiome; Humans; Magnetic Resonance Spectroscopy; Metabolome; Metabolomics; Mice; Mice, Inbred Strains; Vancomycin | 2018 |
Effects of Microplate Type and Broth Additives on Microdilution MIC Susceptibility Assays.
Topics: Aminoglycosides; Anti-Bacterial Agents; Calcium; Ciprofloxacin; Colistin; Culture Media; Depsipeptides; Escherichia coli; Factor Analysis, Statistical; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Penicillin G; Plastics; Polymyxin B; Polysorbates; Rifampin; Teicoplanin; Trimethoprim; Vancomycin | 2019 |
A Stent Graft Visualised Through an Infected Haemodialysis Graft Pseudoaneurysm.
Topics: Aneurysm, False; Anti-Bacterial Agents; Blood Vessel Prosthesis; Ciprofloxacin; Humans; Male; Middle Aged; Prosthesis-Related Infections; Renal Dialysis; Stents; Vancomycin | 2019 |
Long-term impact of oral vancomycin, ciprofloxacin and metronidazole on the gut microbiota in healthy humans.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Biodiversity; Ciprofloxacin; Feces; Gastrointestinal Microbiome; Healthy Volunteers; Humans; Male; Metronidazole; Time Factors; Vancomycin; Young Adult | 2019 |
Selection of an appropriate empiric antibiotic regimen in hematogenous vertebral osteomyelitis.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Empirical Research; Enterobacteriaceae; Female; Gene Expression; Humans; Levofloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Retrospective Studies; Rifampin; Spine; Streptococcus; Vancomycin | 2019 |
The first isolation of Clostridium difficile RT078/ST11 from pigs in China.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Chickens; China; Ciprofloxacin; Clostridioides difficile; Ducks; Imipenem; Metronidazole; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction; Ribotyping; Swine; Tetracycline; Vancomycin | 2019 |
Antibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria.
Topics: Adenosine; Animals; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; In Vitro Techniques; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Prosthesis-Related Infections; Pseudomonas aeruginosa; Purinergic P2Y Receptor Antagonists; Rifampin; Specific Pathogen-Free Organisms; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus agalactiae; Ticagrelor; Vancomycin; Vancomycin-Resistant Enterococci | 2019 |
Effect of Ceftaroline, Vancomycin, Gentamicin, Macrolides, and Ciprofloxacin against Methicillin-Resistant
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Gentamicins; Humans; Macrolides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Vancomycin | 2020 |
Mechanism of formation governs the mechanism of release of antibiotics from calcium phosphate nanopowders and cements in a drug-dependent manner.
Topics: Anti-Bacterial Agents; Calcium Phosphates; Chitosan; Ciprofloxacin; Drug Carriers; Drug Liberation; Gelatin; Hydrogen-Ion Concentration; Hydroxyapatites; Kinetics; Nanostructures; Vancomycin | 2019 |
Antimicrobial activity and biocompatibility of slow-release hyaluronic acid-antibiotic conjugated particles.
Topics: Administration, Ophthalmic; Anti-Bacterial Agents; Bacillus subtilis; Ciprofloxacin; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Liberation; Eye Infections, Bacterial; Humans; Hyaluronic Acid; Kinetics; Pseudomonas aeruginosa; Solubility; Staphylococcus; Vancomycin | 2020 |
Elizabethkingia anophelis Infection in Infants, Cambodia, 2012-2018.
Topics: Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Female; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Infant, Newborn; Microbial Sensitivity Tests; Vancomycin | 2020 |
Bacterial keratitis due to Moraxella nonliquefaciens.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Corneal Opacity; Corneal Ulcer; Drug Substitution; Eye Infections, Bacterial; Humans; Hyphema; Male; Moraxella; Moraxellaceae Infections; Vancomycin | 2020 |
The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; China; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; DNA Gyrase; Drug Resistance, Bacterial; Enterotoxins; Fluoroquinolones; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Moxifloxacin; Vancomycin | 2020 |
Early neonatal sepsis and meningitis caused by Elizabethkingia meningoseptica in Saudi Arabia.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Flavobacteriaceae; Flavobacteriaceae Infections; Humans; Infant, Newborn; Meningitis, Bacterial; Rifampin; Saudi Arabia; Sepsis; Treatment Outcome; Vancomycin | 2020 |
RNA Sequencing Identifies a Common Physiology in Vancomycin- and Ciprofloxacin-Tolerant Staphylococcus aureus Induced by
Topics: Anti-Bacterial Agents; Ciprofloxacin; Microbial Sensitivity Tests; Mutation; Sequence Analysis, RNA; Staphylococcus aureus; Vancomycin | 2020 |
Adsorption of vancomycin, gentamycin, ciprofloxacin and tygecycline on the filters in continuous renal replacement therapy circuits: in full blood in vitro study.
Topics: Acrylic Resins; Adsorption; Animals; Anti-Bacterial Agents; Ciprofloxacin; Continuous Renal Replacement Therapy; Gentamicins; Hemofiltration; Membranes, Artificial; Polymers; Sulfones; Tigecycline; Vancomycin | 2021 |
Maternal antibiotic administration during a critical developmental window has enduring neurobehavioural effects in offspring mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anxiety; Ciprofloxacin; Cognition; Female; Homing Behavior; Imipenem; Male; Metronidazole; Mice; Mice, Inbred C57BL; Penicillin V; Pregnancy; Prenatal Exposure Delayed Effects; Social Behavior; Vancomycin; Vocalization, Animal | 2021 |
Occurrence of multidrug-resistant Enterococcus faecium isolated from environmental samples.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ciprofloxacin; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Environmental Microbiology; Fluoroquinolones; Gram-Positive Bacterial Infections; Linezolid; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Vancomycin; Virulence; Virulence Factors | 2021 |
Moraxella nonliquefaciens superinfecting herpes simplex keratitis.
Topics: Acyclovir; Aged, 80 and over; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Cyclopentolate; Female; Humans; Keratitis, Herpetic; Moraxella; Prednisolone; Vancomycin | 2022 |
Influence of sub-inhibitory concentrations of antimicrobials on micrococcal nuclease and biofilm formation in Staphylococcus aureus.
Topics: Anti-Infective Agents; Biofilms; Ciprofloxacin; Doxycycline; Erythromycin; Gentamicins; Micrococcal Nuclease; Polysaccharides, Bacterial; Resveratrol; Staphylococcus aureus; Stem Cells; Vancomycin | 2021 |
Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Bacteremia; Child; Ciprofloxacin; Febrile Neutropenia; Female; Humans; Imipenem; Leukemia, Myeloid, Acute; Male; Mycoses; Vancomycin; Voriconazole | 2021 |
Corynebacterium Keratitis: Pure Versus Mixed Infection and Antibiotic Susceptibility Patterns From Different Tertiary Eye Care Centers.
Topics: Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Coinfection; Corynebacterium; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Retrospective Studies; Tertiary Care Centers; Vancomycin | 2022 |
Long-term modification of gut microbiota by broad-spectrum antibiotics improves stroke outcome in rats.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Cytokines; Endothelin-1; Fatty Acids, Volatile; Gastrointestinal Microbiome; Infarction; Meropenem; Metronidazole; Rats; Stroke; Vancomycin | 2022 |
Current state of antimicrobial stewardship and organ transplantation in Spain.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antimicrobial Stewardship; Ciprofloxacin; Humans; Meropenem; Organ Transplantation; Spain; Vancomycin | 2022 |
Impact of narrowing perioperative antibiotic prophylaxis for left ventricular assist device implantation.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Ciprofloxacin; Fluconazole; Heart Failure; Heart-Assist Devices; Humans; Retrospective Studies; Rifampin; Treatment Outcome; Vancomycin | 2022 |
Prevalence and antimicrobial susceptibility of Enterococcus spp. from urine of dogs and cats in northwestern Croatia.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cat Diseases; Cats; Chloramphenicol; Ciprofloxacin; Croatia; Dog Diseases; Dogs; Drug Resistance, Bacterial; Enrofloxacin; Enterococcus; Enterococcus faecium; Gentamicins; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Nitrofurantoin; Penicillins; Prevalence; Rifampin; Streptomycin; Tetracycline; Vancomycin | 2022 |
Drug repurposing strategy: An emerging approach to identify potential therapeutics for treatment of bovine mastitis.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bilirubin; Cattle; Cefoxitin; Ciprofloxacin; Drug Repositioning; Female; Gentamicins; Ivermectin; Ketoprofen; Mastitis, Bovine; Meloxicam; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxytetracycline; Rabbits; Staphylococcal Infections; Sulfamethoxazole; Tylosin; Vancomycin | 2022 |
Analysis of virulence genes, drug resistance detection, and pathogenicity in Enterococcus from farm animals.
Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; Cattle; Cefotaxime; Chickens; Ciprofloxacin; Dogs; Drug Resistance; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Levofloxacin; Mice; Microbial Sensitivity Tests; Sulfamethoxazole; Swine; Vancomycin; Virulence; Virulence Factors | 2022 |
VanA-Enterococcus faecalis in Poland: hospital population clonal structure and vanA mobilome.
Topics: Aminoglycosides; Bacterial Proteins; Carbon-Oxygen Ligases; Ciprofloxacin; DNA Transposable Elements; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospitals; Humans; Multilocus Sequence Typing; Poland; Teicoplanin; Vancomycin | 2022 |
Characterization of oxacillin-resistant Staphylococcus lugdunensis isolated from sterile body fluids in a medical center in Taiwan: A 12-year longitudinal epidemiological study.
Topics: Anti-Bacterial Agents; Body Fluids; Ciprofloxacin; Erythromycin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Staphylococcal Infections; Staphylococcus lugdunensis; Sulfamethoxazole; Taiwan; Teicoplanin; Trimethoprim; Vancomycin | 2023 |
Topics: Agar; Bacterial Typing Techniques; Base Composition; Catalase; Charcoal; Ciprofloxacin; Cycloheximide; Cysteine; DNA, Bacterial; Fatty Acids; Gelatinases; Glycine; Hippurates; Legionella; Nucleotides; Phylogeny; Polymyxin B; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Vancomycin; Water | 2022 |
Characterization and Transferability of erm and tet Antibiotic Resistance Genes in Lactobacillus spp. Isolated from Traditional Fermented Milk.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Lactobacillus; Microbial Sensitivity Tests; Milk; RNA, Ribosomal, 16S; Sodium Chloride; Streptomycin; Trimethoprim; Vancomycin | 2022 |
The Medium Composition Impacts
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2022 |
Molecular Detection of
Topics: Amikacin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Erythromycin; Gentamicins; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Urinary Tract Infections; Vancomycin | 2022 |
The intestinal carrier status of Enterococcus spp. in children: clonal diversity and alterations in resistance phenotypes before and after admission to a pediatric intensive care unit.
Topics: Ampicillin; Child; Ciprofloxacin; Enterococcus; Hospitalization; Humans; Intensive Care Units, Pediatric; Phenotype; Phylogeny; Random Amplified Polymorphic DNA Technique; Vancomycin | 2023 |